Thioredoxins (Trxs), glutaredoxins (Grxs), and peroxiredoxins (Prxs) have been characterized as electron donors, guards of the intracellular redox state, and “antioxidants”. Today, these redox catalysts are increasingly recognized for their specific role in redox signaling. The number of publications published on the functions of these proteins continues to increase exponentially. The field is experiencing an exciting transformation, from looking at a general redox homeostasis and the pathological oxidative stress model to realizing redox changes as a part of localized, rapid, specific, and reversible redox-regulated signaling events. This review summarizes the almost 50 years of research on these proteins, focusing primarily on data from vertebrates and mammals. The role of Trx fold proteins in redox signaling is discussed by looking at reaction mechanisms, reversible oxidative post-translational modifications of proteins, and characterized interaction partners. On the basis of this analysis, the specific regulatory functions are exemplified for the cellular processes of apoptosis, proliferation, and iron metabolism. The importance of Trxs, Grxs, and Prxs for human health is addressed in the second part of this review, that is, their potential impact and functions in different cell types, tissues, and various pathological conditions. Antioxid. Redox Signal. 19, 1539–1605.
AbateC, PatelL, RauscherFJ3rd, CurranT. Redox regulation of fos and jun DNA-binding activity in vitro. Science, 249:1157–1161. 1990.
2.
AbdiuA, NakamuraH, SahafB, YodoiJ, HolmgrenA, RosénA. Thioredoxin blood level increases after severe burn injury. Antioxid Redox Signal, 2:707–716. 2000.
3.
AdelmanDM, GertsensteinM, NagyA, SimonMC, MaltepeE. Placental cell fates are regulated in vivo by HIF-mediated hypoxia responses. Genes Dev, 14:3191–3203. 2000.
AdluriRS, ThirunavukkarasuM, ZhanL, AkitaY, SamuelSM, OtaniH, HoY-S, MaulikG, MaulikN. Thioredoxin 1 enhances neovascularization and reduces ventricular remodeling during chronic myocardial infarction: a study using thioredoxin 1 transgenic mice. J Mol Cell Cardiol, 50:239–247. 2011.
7.
AdvaniA, GilbertRE, ThaiK, GowRM, LanghamRG, CoxAJ, ConnellyKA, ZhangY, HerzenbergAM, ChristensenPK, PollockCA, QiW, TanSM, ParvingH-H, KellyDJ. Expression, localization, and function of the thioredoxin system in diabetic nephropathy. J Am Soc Nephrol, 20:730–741. 2009.
8.
AesifSW, AnathyV, KuipersI, GualaAS, ReissJN, HoY-S, Janssen-HeiningerYMW. Ablation of glutaredoxin-1 attenuates lipopolysaccharide-induced lung inflammation and alveolar macrophage activation. Am J Respir Cell Mol Biol, 44:491–499. 2011.
Agrawal-SinghS, IskenF, AgelopoulosK, KleinH-U, ThoennissenNH, KoehlerG, HascherA, BäumerN, BerdelWE, ThiedeC, EhningerG, BeckerA, SchlenkeP, WangY, McClellandM, KrugU, KoschmiederS, BüchnerT, YuD-Y, SinghSV, HansenK, ServeH, DugasM, Müller-TidowC. Genome-wide analysis of histone H3 acetylation patterns in AML identifies PRDX2 as an epigenetically silenced tumor suppressor gene. Blood, 119:2346–2357. 2012.
11.
AhnBY, MossB. Glutaredoxin homolog encoded by vaccinia virus is a virion-associated enzyme with thioltransferase and dehydroascorbate reductase activities. Proc Natl Acad Sci U S A, 89:7060–7064. 1992.
12.
AhsanMK, LekliI, RayD, YodoiJ, DasDK. Redox regulation of cell survival by the thioredoxin superfamily: an implication of redox gene therapy in the heart. Antioxid Redox Signal, 11:2741–2758. 2009.
13.
AilletF, MasutaniH, ElbimC, RaoulH, ChêneL, NugeyreMT, PayaC, Barré-SinoussiF, Gougerot-PocidaloMA, IsraëlN. Human immunodeficiency virus induces a dual regulation of Bcl-2, resulting in persistent infection of CD4(+) T- or monocytic cell lines. J Virol, 72:9698–9705. 1998.
14.
AkerboomTP, SiesH. Assay of glutathione, glutathione disulfide, and glutathione mixed disulfides in biological samples. Methods Enzymol, 77:373–382. 1981.
15.
AkifM, KhareG, TyagiAK, MandeSC, SardesaiAA. Functional studies of multiple thioredoxins from Mycobacterium tuberculosis. J Bacteriol, 190:7087–7095. 2008.
16.
AkterinS, CowburnRF, Miranda-VizueteA, JiménezA, BogdanovicN, WinbladB, Cedazo-MinguezA. Involvement of glutaredoxin-1 and thioredoxin-1 in beta-amyloid toxicity and Alzheimer's disease. Cell Death Differ, 13:1454–1465. 2006.
17.
AlamZI, DanielSE, LeesAJ, MarsdenDC, JennerP, HalliwellB. A generalised increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease. J Neurochem, 69:1326–1329. 1997.
18.
AlbrechtSC, BarataAG, GrosshansJ, TelemanAA, DickTP. In vivo mapping of hydrogen peroxide and oxidized glutathione reveals chemical and regional specificity of redox homeostasis. Cell Metab, 14:819–829. 2011.
19.
Al-GayyarMMH, AbdelsaidMA, MatragoonS, PillaiBA, El-RemessyAB. Thioredoxin interacting protein is a novel mediator of retinal inflammation and neurotoxicity. Br J Pharmacol, 164:170–180. 2011.
20.
Al-JawadFH, SahibAS, Al-KaisyAA. Role of antioxidants in the treatment of burn lesions. Ann Burns Fire Disasters, 21:186–191. 2008.
21.
AltschmiedJ, HaendelerJ. Thioredoxin-1 and endothelial cell aging: role in cardiovascular diseases. Antioxid Redox Signal, 11:1733–1740. 2009.
22.
AmeisenJC. Programmed cell death (apoptosis) and cell survival regulation: relevance to AIDS and cancer. AIDS, 8:1197–1213. 1994.
23.
AnderssonM, HolmgrenA, SpyrouG. NK-lysin, a disulfide-containing effector peptide of T-lymphocytes, is reduced and inactivated by human thioredoxin reductase. Implication for a protective mechanism against NK-lysin cytotoxicity. J Biol Chem, 271:10116–10120. 1996.
24.
AndricopuloAD, AkoachereMB, KroghR, NickelC, McLeishMJ, KenyonGL, ArscottLD, WilliamsCHJr., Davioud-CharvetE, BeckerK. Specific inhibitors of Plasmodium falciparum thioredoxin reductase as potential antimalarial agents. Bioorg Med Chem Lett, 16:2283–2292. 2006.
25.
AngeliniG, GardellaS, ArdyM, CirioloMR, FilomeniG, Di TrapaniG, ClarkeF, SitiaR, RubartelliA. Antigen-presenting dendritic cells provide the reducing extracellular microenvironment required for T lymphocyte activation. Proc Natl Acad Sci U S A, 99:1491–1496. 2002.
26.
Aon-BertolinoML, RomeroJI, GaleanoP, HolubiecM, BadorreyMS, SaracenoGE, HanschmannE-M, LilligCH, CapaniF. Thioredoxin and glutaredoxin system proteins-immunolocalization in the rat central nervous system. Biochim Biophys Acta, 1810:93–110. 2011.
27.
AotaM, MatsudaK, IsowaN, WadaH, YodoiJ, BanT. Protection against reperfusion-induced arrhythmias by human thioredoxin. J Cardiovasc Pharmacol, 27:727–732. 1996.
28.
ArnérESJ. Focus on mammalian thioredoxin reductases—Important selenoproteins with versatile functions. Biochim Biophys Acta, 1790:495–526. 2009.
29.
ArnérESJ, HolmgrenA. The thioredoxin system in cancer. Semin Cancer Biol, 16:420–426. 2006.
30.
ArrigoniFI, HislopAA, PollockJS, HaworthSG, MitchellJA. Birth upregulates nitric oxide synthase activity in the porcine lung. Life Sci, 70:1609–1620. 2002.
31.
AshfaqS, AbramsonJL, JonesDP, RhodesSD, WeintraubWS, HooperWC, VaccarinoV, HarrisonDG, QuyyumiAA. The relationship between plasma levels of oxidized and reduced thiols and early atherosclerosis in healthy adults. J Am Coll Cardiol, 47:1005–1011. 2006.
32.
AtharM. Oxidative stress and experimental carcinogenesis. Indian J Exp Biol, 40:656–667. 2002.
33.
AuwerxJ, IsacssonO, SöderlundJ, BalzariniJ, JohanssonM, LundbergM. Human glutaredoxin-1 catalyzes the reduction of HIV-1 gp120 and CD4 disulfides and its inhibition reduces HIV-1 replication. Int J Biochem Cell Biol, 41:1269–1275. 2009.
34.
AvilaPC, KropotovAV, KrutilinaR, KrasnodembskayA, TomilinNV, SerikovVB. Peroxiredoxin V contributes to antioxidant defense of lung epithelial cells. Lung, 186:103–114. 2008.
35.
BachschmidMM, XuS, Maitland-ToolanKA, HoY-S, CohenRA, MatsuiR. Attenuated cardiovascular hypertrophy and oxidant generation in response to angiotensin II infusion in glutaredoxin-1 knockout mice. Free Radic Biol Med, 49:1221–1229. 2010.
36.
BaiJ, NakamuraH, HattoriI, TanitoM, YodoiJ. Thioredoxin suppresses 1-methyl-4-phenylpyridinium-induced neurotoxicity in rat PC12 cells. Neurosci Lett, 321:81–84. 2002.
37.
BaiX-Y, MaY, DingR, FuB, ShiS, ChenX-M. miR-335 and miR-34a Promote renal senescence by suppressing mitochondrial antioxidative enzymes. J Am Soc Nephrol, 22:1252–1261. 2011.
38.
BallKA, NelsonAW, FosterDG, PoytonRO. Nitric oxide produced by cytochrome c oxidase helps stabilize HIF-1α in hypoxic mammalian cells. Biochem Biophys Res Commun, 420:727–732. 2012.
39.
BanhamHAL, HaldaneJS, SavageT. The presence post mortem of nitricoxide-haemoglobin. Br Med J, 2:187–189. 1925.
40.
BarberSC, MeadRJ, ShawPJ. Oxidative stress in ALS: a mechanism of neurodegeneration and a therapeutic target. Biochim Biophys Acta, 1762:1051–1067. 2006.
41.
BaroneE, CeniniG, SultanaR, Di DomenicoF, FioriniA, PerluigiM, NoelT, WangC, MancusoC, St ClairDK, ButterfieldDA. Lack of p53 decreases basal oxidative stress levels in the brain through upregulation of thioredoxin-1, biliverdin reductase-A, manganese superoxide dismutase, and nuclear factor kappa-B. Antioxid Redox Signal, 16:1407–1420. 2012.
42.
Barranco-MedinaS, LázaroJ-J, DietzK-J. The oligomeric conformation of peroxiredoxins links redox state to function. FEBS Lett, 583:1809–1816. 2009.
43.
BaskarR, BianJ. Hydrogen sulfide gas has cell growth regulatory role. Eur J Pharmacol, 656:5–9. 2011.
44.
BassoM, GiraudoS, CorpilloD, BergamascoB, LopianoL, FasanoM. Proteome analysis of human substantia nigra in Parkinson's disease. Proteomics, 4:3943–3952. 2004.
45.
BastA, WolfG, OberbäumerI, WaltherR. Oxidative and nitrosative stress induces peroxiredoxins in pancreatic beta cells. Diabetologia, 45:867–876. 2002.
46.
BasuA, BanerjeeH, RojasH, MartinezSR, RoyS, JiaZ, LillyMB, De LeónM, CasianoCA. Differential expression of peroxiredoxins in prostate cancer: consistent upregulation of PRDX3 and PRDX4. Prostate, 71:755–765. 2011.
47.
BazzichiA, IncapreraM, GarzelliC. Effect of Escherichia-coli thioredoxin, a homolog to the adult T-cell leukemia-derived factor, on epstein-barr virus-transformed B-lymphocytes. Int J Oncol, 5:41–46. 1994.
48.
BeckerK, GromerS, SchirmerRH, MüllerS. Thioredoxin reductase as a pathophysiological factor and drug target. Eur J Biochem, 267:6118–6125. 2000.
49.
BeckM. Selenium and viral infections. Selenium—Its Molecular Biology and Role in Human Health. HatfieldDL, BerryMJ, GladyshevVN. Heidelberg, Germany: Springer, 2006; 287–298.
50.
BeckmanKB, AmesBN. The free radical theory of aging matures. Physiol Rev, 78:547–581. 1998.
51.
BedardK, KrauseK-H. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev, 87:245–313. 2007.
52.
BenardO, BalasubramanianKA. Purification and properties of thioltransferase from monkey small intestinal mucosa: its role in protein-S-thiolation. Int J Biochem Cell Biol, 28:1051–1059. 1996.
53.
BenharM, ForresterMT, HessDT, StamlerJS. Regulated protein denitrosylation by cytosolic and mitochondrial thioredoxins. Science, 320:1050–1054. 2008.
54.
BerggrenM, GallegosA, GasdaskaJR, GasdaskaPY, WarnekeJ, PowisG. Thioredoxin and thioredoxin reductase gene expression in human tumors and cell lines, and the effects of serum stimulation and hypoxia. Anticancer Res, 16:3459–3466. 1996.
55.
BerggrenMI, HusbeckB, SamulitisB, BakerAF, GallegosA, PowisG. Thioredoxin peroxidase-1 (peroxiredoxin-1) is increased in thioredoxin-1 transfected cells and results in enhanced protection against apoptosis caused by hydrogen peroxide but not by other agents including dexamethasone, etoposide, and doxorubicin. Arch Biochem Biophys, 392:103–109. 2001.
56.
BerndtC, HudemannC, HanschmannE-M, AxelssonR, HolmgrenA, LilligCH. How does iron-sulfur cluster coordination regulate the activity of human glutaredoxin 2?Antioxid Redox Signal, 9:151–157. 2007.
57.
BerndtC, LilligCH, HolmgrenA. Thioredoxins and glutaredoxins as facilitators of protein folding. Biochim Biophys Acta, 1783:641–650. 2008.
58.
BertiniR, HowardOM, DongHF, OppenheimJJ, BizzarriC, SergiR, CaselliG, PaglieiS, RominesB, WilshireJA, MengozziM, NakamuraH, YodoiJ, PekkariK, GurunathR, HolmgrenA, HerzenbergLA, HerzenbergLA, GhezziP. Thioredoxin, a redox enzyme released in infection and inflammation, is a unique chemoattractant for neutrophils, monocytes, and T cells. J Exp Med, 189:1783–1789. 1999.
59.
BeutlerE. Iron storage disease: facts, fiction and progress. Blood Cells Mol Dis, 39:140–147. 2007.
60.
BharathS, HsuM, KaurD, RajagopalanS, AndersenJK. Glutathione, iron and Parkinson's disease. Biochem Pharmacol, 64:1037–1048. 2002.
61.
BickersDR, AtharM. Oxidative stress in the pathogenesis of skin disease. J Invest Dermatol, 126:2565–2575. 2006.
62.
BigelowDJ, SquierTC. Thioredoxin-dependent redox regulation of cellular signaling and stress response through reversible oxidation of methionines. Mol Biosyst, 7:2101–2109. 2011.
63.
BiguetC, WakasugiN, MishalZ, HolmgrenA, ChouaibS, TurszT, WakasugiH. Thioredoxin increases the proliferation of human B-cell lines through a protein kinase C-dependent mechanism. J Biol Chem, 269:28865–28870. 1994.
64.
BiteauB, LabarreJ, ToledanoMB. ATP-dependent reduction of cysteine-sulphinic acid by S. cerevisiae sulphiredoxin. Nature, 425:980–984. 2003.
65.
BizzarriC, HolmgrenA, PekkariK, ChangG, ColottaF, GhezziP, BertiniR. Requirements for the different cysteines in the chemotactic and desensitizing activity of human thioredoxin. Antioxid Redox Signal, 7:1189–1194. 2005.
66.
BjörnstedtM, XueJ, HuangW, AkessonB, HolmgrenA. The thioredoxin and glutaredoxin systems are efficient electron donors to human plasma glutathione peroxidase. J Biol Chem, 269:29382–29384. 1994.
67.
BlauwkampMN, YuJ, SchinMA, BurkeKA, BerryMJ, CarlsonBA, BrosiusFC3rd, KoenigRJ. Podocyte specific knock out of selenoproteins does not enhance nephropathy in streptozotocin diabetic C57BL/6 mice. BMC Nephrol, 9:7. 2008.
68.
BokovA, ChaudhuriA, RichardsonA. The role of oxidative damage and stress in aging. Mech Ageing Dev, 125:811–826. 2004.
69.
BorisenkoG, KaganVE, BayirHA, BelikovaNA, KapralovO, TyurinaYY, TyurinVA, JiangJ, StoyanovskyDA, WipfP, KochanekPM, GreenbergerJS, PittB, ShvedovaAA. Cytochrome c/cardiolipin relations in mitochondria: a kiss of death. Free Radic Biol Med, 46:1439–1453. 2009.
70.
BoulosS, MeloniBP, ArthurPG, BojarskiC, KnuckeyNW. Peroxiredoxin 2 overexpression protects cortical neuronal cultures from ischemic and oxidative injury but not glutamate excitotoxicity, whereas Cu/Zn superoxide dismutase 1 overexpression protects only against oxidative injury. J Neurosci Res, 85:3089–3097. 2007.
BradyKD, GiegelDA, GrinnellC, LunneyE, TalanianRV, WongW, WalkerN. A catalytic mechanism for caspase-1 and for bimodal inhibition of caspase-1 by activated aspartic ketones. Bioorg Med Chem, 7:621–631. 1999.
73.
BrandMD. The sites and topology of mitochondrial superoxide production. Exp Gerontol, 45:466–472. 2010.
74.
BraskettM, RiedlMA. Novel antioxidant approaches to the treatment of upper airway inflammation. Curr Opin Allergy Clin Immunol, 10:34–41. 2010.
75.
BräutigamL, SchütteLD, GodoyJR, ProzorovskiT, GellertM, HauptmannG, HolmgrenA, LilligCH, BerndtC. Vertebrate-specific glutaredoxin is essential for brain development. Proc Natl Acad Sci U S A, 108:20532–20537. 2011.
76.
BreaD, Rodríguez-GonzálezR, SobrinoT, Rodríguez-YañezM, BlancoM, CastilloJ. Proteomic analysis shows differential protein expression in endothelial progenitor cells between healthy subjects and ischemic stroke patients. Neurol Res, 33:1057–1063. 2011.
77.
Brigelius-FlohéR, FlohéL. Basic principles and emerging concepts in the redox control of transcription factors. Antioxid Redox Signal, 15:2335–2381. 2011.
78.
BrownleeM. Biochemistry and molecular cell biology of diabetic complications. Nature, 414:813–820. 2001.
79.
BruntonTL. Experimental Investigation of the Action of Medicines. London: J. and A. Churchill, 1875.
80.
BuchananBB, AdamidiC, LozanoRM, YeeBC, MommaM, KobrehelK, ErmelR, FrickOL. Thioredoxin-linked mitigation of allergic responses to wheat. Proc Natl Acad Sci U S A, 94:5372–5377. 1997.
81.
BuchananBB, BalmerY. Redox regulation: a broadening horizon. Annu Rev Plant Biol, 56:187–220. 2005.
82.
BuchananBB, WolosiukRA. Photosynthetic regulatory protein found in animal and bacterial cells. Nature, 264:669–670. 1976.
Burke-GaffneyA, CallisterMEJ, NakamuraH. Thioredoxin: friend or foe in human disease?Trends Pharmacol Sci, 26:398–404. 2005.
85.
BushwellerJH, AslundF, WüthrichK, HolmgrenA. Structural and functional characterization of the mutant Escherichia coli glutaredoxin (C14—-S) and its mixed disulfide with glutathione. Biochemistry, 31:9288–9293. 1992.
86.
ButterfieldDA, PerluigiM, SultanaR. Oxidative stress in Alzheimer's disease brain: new insights from redox proteomics. Eur J Pharmacol, 545:39–50. 2006.
87.
ButterfieldLH, MerinoA, GolubSH, ShauH. From cytoprotection to tumor suppression: the multifactorial role of peroxiredoxins. Antioxid Redox Signal, 1:385–402. 1999.
88.
BylundJ, BrownKL, MovitzC, DahlgrenC, KarlssonA. Intracellular generation of superoxide by the phagocyte NADPH oxidase: how, where, and what for?Free Radic Biol Med, 49:1834–1845. 2010.
89.
CabreiroF, PicotCR, FriguetB, PetropoulosI. Methionine sulfoxide reductases: relevance to aging and protection against oxidative stress. Ann N Y Acad Sci, 1067:37–44. 2006.
90.
CagnolS, ChambardJ-C. ERK and cell death: mechanisms of ERK-induced cell death—apoptosis, autophagy and senescence. FEBS J, 277:2–21. 2010.
91.
CaiJ, NelsonKC, WuM, SternbergPJr., JonesDP. Oxidative damage and protection of the RPE. Prog Retin Eye Res, 19:205–221. 2000.
CalabreseV, CorneliusC, MaiolinoL, LucaM, ChiaramonteR, ToscanoMA, SerraA. Oxidative stress, redox homeostasis and cellular stress response in Ménière's disease: role of vitagenes. Neurochem Res, 35:2208–2217. 2010.
94.
CamaschellaC. Understanding iron homeostasis through genetic analysis of hemochromatosis and related disorders. Blood, 106:3710–3717. 2005.
95.
CamaschellaC, CampanellaA, De FalcoL, BoschettoL, MerliniR, SilvestriL, LeviS, IolasconA. The human counterpart of zebrafish shiraz shows sideroblastic-like microcytic anemia and iron overload. Blood, 110:1353–1358. 2007.
96.
CameronNE, CotterMA. Pro-inflammatory mechanisms in diabetic neuropathy: focus on the nuclear factor kappa B pathway. Curr Drug Targets, 9:60–67. 2008.
CapaniF, LoidlCF, PiehlLL, FacorroG, De PaoliT, HagerA. Long term production of reactive oxygen species during perinatal asphyxia in the rat central nervous system: effects of hypothermia. Int J Neurosci, 113:641–654. 2003.
100.
CassoD, BeachD. A mutation in a thioredoxin reductase homolog suppresses p53-induced growth inhibition in the fission yeast Schizosaccharomyces pombe. Mol Gen Genet, 252:518–529. 1996.
101.
CeylanS, SeidelV, ZiebartN, BerndtC, DirdjajaN, Krauth-SiegelRL. The dithiol glutaredoxins of african trypanosomes have distinct roles and are closely linked to the unique trypanothione metabolism. J Biol Chem, 285:35224–35237. 2010.
102.
ChaeHZ, KimHJ, KangSW, RheeSG. Characterization of three isoforms of mammalian peroxiredoxin that reduce peroxides in the presence of thioredoxin. Diabetes Res Clin Pract, 45:101–112. 1999.
103.
ChaeHZ, KimIH, KimK, RheeSG. Cloning, sequencing, and mutation of thiol-specific antioxidant gene of Saccharomyces cerevisiae. J Biol Chem, 268:16815–16821. 1993.
104.
ChaeHZ, RobisonK, PooleLB, ChurchG, StorzG, RheeSG. Cloning and sequencing of thiol-specific antioxidant from mammalian brain: alkyl hydroperoxide reductase and thiol-specific antioxidant define a large family of antioxidant enzymes. Proc Natl Acad Sci U S A, 91:7017–7021. 1994.
105.
ChaH, KimJM, OhJG, JeongMH, ParkCS, ParkJ, JeongHJ, ParkBK, LeeY-H, JeongD, YangDK, BerneckerOY, KimDH, HajjarRJ, ParkWJ. PICOT is a critical regulator of cardiac hypertrophy and cardiomyocyte contractility. J Mol Cell Cardiol, 45:796–803. 2008.
106.
ChaiTF, LeckYC, HeH, YuF-X, LuoY, HagenT. Hypoxia-inducible factor independent down-regulation of thioredoxin-interacting protein in hypoxia. FEBS Lett, 585:492–498. 2011.
107.
ChakrapaniB, YedavallyS, LeverenzV, GiblinFJ, ReddyVN. Simultaneous measurement of reduced and oxidized glutathione in human aqueous humor and cataracts by electrochemical detection. Ophthalmic Res, 27,Suppl 1:69–77. 1995.
108.
ChaM-K, KimI-H. Preferential overexpression of glutaredoxin3 in human colon and lung carcinoma. Cancer Epidemiol, 33:281–287. 2009.
109.
ChaMK, YunCH, KimIH. Interaction of human thiol-specific antioxidant protein 1 with erythrocyte plasma membrane. Biochemistry, 39:6944–6950. 2000.
110.
ChanceB, OshinoN. Kinetics and mechanisms of catalase in peroxisomes of the mitochondrial fraction. Biochem J, 122:225–233. 1971.
111.
ChandelNS, McClintockDS, FelicianoCE, WoodTM, MelendezJA, RodriguezAM, SchumackerPT. Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: a mechanism of O2 sensing. J Biol Chem, 275:25130–25138. 2000.
112.
ChangJW, LeeSH, JeongJY, ChaeHZ, KimYC, ParkZ-Y, YooYJ. Peroxiredoxin-I is an autoimmunogenic tumor antigen in non-small cell lung cancer. FEBS Lett, 579:2873–2877. 2005.
113.
ChangT-S, JeongW, ChoiSY, YuS, KangSW, RheeSG. Regulation of peroxiredoxin I activity by Cdc2-mediated phosphorylation. J Biol Chem, 277:25370–25376. 2002.
114.
ChangY-C, HuangC-N, LinC-H, ChangH-C, WuC-C. Mapping protein cysteine sulfonic acid modifications with specific enrichment and mass spectrometry: an integrated approach to explore the cysteine oxidation. Proteomics, 10:2961–2971. 2010.
115.
ChenC-L, LinC-F, ChangW-T, HuangW-C, TengC-F, LinY-S. Ceramide induces p38 MAPK and JNK activation through a mechanism involving a thioredoxin-interacting protein-mediated pathway. Blood, 111:4365–4374. 2008.
116.
ChengN-H, ZhangW, ChenW-Q, JinJ, CuiX, ButteNF, ChanL, HirschiKD. A mammalian monothiol glutaredoxin, Grx3, is critical for cell cycle progression during embryogenesis. FEBS J, 278:2525–2539. 2011.
117.
ChenJ, FontesG, SaxenaG, PoitoutV, ShalevA. Lack of TXNIP protects against mitochondria-mediated apoptosis but not against fatty acid-induced ER stress-mediated beta-cell death. Diabetes, 59:440–447. 2010.
118.
ChenJ-H, ChangY-W, YaoC-W, ChiuehT-S, HuangS-C, ChienK-Y, ChenA, ChangF-Y, WongC-H, ChenY-J. Plasma proteome of severe acute respiratory syndrome analyzed by two-dimensional gel electrophoresis and mass spectrometry. Proc Natl Acad Sci U S A, 101:17039–17044. 2004.
119.
ChenJ, HuiST, CoutoFM, MungrueIN, DavisDB, AttieAD, LusisAJ, DavisRA, ShalevA. Thioredoxin-interacting protein deficiency induces Akt/Bcl-xL signaling and pancreatic beta-cell mass and protects against diabetes. FASEB J, 22:3581–3594. 2008.
120.
ChenJ, SaxenaG, MungrueIN, LusisAJ, ShalevA. Thioredoxin-interacting protein: a critical link between glucose toxicity and beta-cell apoptosis. Diabetes, 57:938–944. 2008.
121.
ChenJW, DodiaC, FeinsteinSI, JainMK, FisherAB. 1-Cys peroxiredoxin, a bifunctional enzyme with glutathione peroxidase and phospholipase A2 activities. J Biol Chem, 275:28421–28427. 2000.
122.
ChenL, NaR, GuM, SalmonAB, LiuY, LiangH, QiW, Van RemmenH, RichardsonA, RanQ. Reduction of mitochondrial H2O2 by overexpressing peroxiredoxin 3 improves glucose tolerance in mice. Aging Cell, 7:866–878. 2008.
123.
ChenM-F, KengPC, ShauH, WuC-T, HuY-C, LiaoS-K, ChenW-C. Inhibition of lung tumor growth and augmentation of radiosensitivity by decreasing peroxiredoxin I expression. Int J Radiat Oncol Biol Phys, 64:581–591. 2006.
124.
ChenQ, AmesBN. Senescence-like growth arrest induced by hydrogen peroxide in human diploid fibroblast F65 cells. Proc Natl Acad Sci U S A, 91:4130–4134. 1994.
125.
ChernatynskayaAV, LooneyB, HuH, ZhuX, XiaC-Q. Administration of recombinant human thioredoxin-1 significantly delays and prevents autoimmune diabetes in nonobese diabetic mice through modulation of autoimmunity. Diabetes Metab Res Rev, 27:809–812. 2011.
ChintaSJ, KumarMJ, HsuM, RajagopalanS, KaurD, RaneA, NichollsDG, ChoiJ, AndersenJK. Inducible alterations of glutathione levels in adult dopaminergic midbrain neurons result in nigrostriatal degeneration. J Neurosci, 27:13997–14006. 2007.
128.
ChoiHS, ParkKJ, HwangSC, ParkHY, KimYS, ParkK. The role of peroxiredoxin III in the ototoxic drug-induced mitochondrial apoptosis of cochlear hair cells. Acta Otolaryngol, 128:944–951. 2008.
ChoksiS, LinY, PobezinskayaY, ChenL, ParkC, MorganM, LiT, JitkaewS, CaoX, KimY-S, KimH-S, LevittP, ShihG, BirreM, DengC-X, LiuZ-G. A HIF-1 target, ATIA, protects cells from apoptosis by modulating the mitochondrial thioredoxin, TRX2. Mol Cell, 42:597–609. 2011.
131.
ChouF-C, SytwuH-K. Overexpression of thioredoxin in islets transduced by a lentiviral vector prolongs graft survival in autoimmune diabetic NOD mice. J Biomed Sci, 16:71. 2009.
132.
ChutkowWA, BirkenfeldAL, BrownJD, LeeH-Y, FrederickDW, YoshiokaJ, PatwariP, KursaweR, CushmanSW, PlutzkyJ, ShulmanGI, SamuelVT, LeeRT. Deletion of the alpha-arrestin protein Txnip in mice promotes adiposity and adipogenesis while preserving insulin sensitivity. Diabetes, 59:1424–1434. 2010.
133.
CircuML, AwTY. Redox biology of the intestine. Free Radic Res, 45:1245–1266. 2011.
134.
CocheméHM, QuinC, McQuakerSJ, CabreiroF, LoganA, PrimeTA, AbakumovaI, PatelJV, FearnleyIM, JamesAM, PorteousCM, SmithRAJ, SaeedS, CarréJE, SingerM, GemsD, HartleyRC, PartridgeL, MurphyMP. Measurement of H2O2 within living Drosophila during aging using a ratiometric mass spectrometry probe targeted to the mitochondrial matrix. Cell Metab, 13:340–350. 2011.
135.
ConradM, JakupogluC, MorenoSG, LipplS, BanjacA, SchneiderM, BeckH, HatzopoulosAK, JustU, SinowatzF, SchmahlW, ChienKR, WurstW, BornkammGW, BrielmeierM. Essential role for mitochondrial thioredoxin reductase in hematopoiesis, heart development, and heart function. Mol Cell Biol, 24:9414–9423. 2004.
136.
CoralK, RamanR, RathiS, RajeshM, SulochanaKN, AngayarkanniN, PaulPG, RamakrishnanS. Plasma homocysteine and total thiol content in patients with exudative age-related macular degeneration. Eye (Lond), 20:203–207. 2006.
137.
Da CostaCA. DJ-1: a newcomer in Parkinson's disease pathology. Curr Mol Med, 7:650–657. 2007.
138.
CummingRC, DarguschR, FischerWH, SchubertD. Increase in expression levels and resistance to sulfhydryl oxidation of peroxiredoxin isoforms in amyloid beta-resistant nerve cells. J Biol Chem, 282:30523–30534. 2007.
139.
CurtsingerJM, SchmidtCS, MondinoA, LinsDC, KedlRM, JenkinsMK, MescherMF. Inflammatory cytokines provide a third signal for activation of naive CD4+ and CD8+ T cells. J Immunol, 162:3256–3262. 1999.
140.
DailyD, Vlamis-GardikasA, OffenD, MittelmanL, MelamedE, HolmgrenA, BarzilaiA. Glutaredoxin protects cerebellar granule neurons from dopamine-induced apoptosis by activating NF-kappa B via Ref-1. J Biol Chem, 276:1335–1344. 2001.
Dalle-DonneI, RossiR, ColomboG, GiustariniD, MilzaniA. Protein S-glutathionylation: a regulatory device from bacteria to humans. Trends Biochem Sci, 34:85–96. 2009.
143.
DammeyerP, ArnérESJ. Human Protein Atlas of redox systems—what can be learnt?Biochim Biophys Acta, 1810:111–138. 2011.
144.
DammeyerP, DamdimopoulosAE, NordmanT, JiménezA, Miranda-VizueteA, ArnérESJ. Induction of cell membrane protrusions by the N-terminal glutaredoxin domain of a rare splice variant of human thioredoxin reductase 1. J Biol Chem, 283:2814–2821. 2008.
145.
DanetGH, PanY, LuongoJL, BonnetDA, SimonMC. Expansion of human SCID-repopulating cells under hypoxic conditions. J Clin Invest, 112:126–135. 2003.
146.
DanielsonSR, AndersenJK. Oxidative and nitrative protein modifications in Parkinson's disease. Free Radic Biol Med, 44:1787–1794. 2008.
147.
DaniilZD, PapageorgiouE, KoutsokeraA, KostikasK, KiropoulosT, PapaioannouAI, GourgoulianisKI. Serum levels of oxidative stress as a marker of disease severity in idiopathic pulmonary fibrosis. Pulm Pharmacol Ther, 21:26–31. 2008.
148.
DasKC, GuoXL, WhiteCW. Induction of thioredoxin and thioredoxin reductase gene expression in lungs of newborn primates by oxygen. Am J Physiol, 276:L530–L539. 1999.
149.
DavisDA, NewcombFM, StarkeDW, OttDE, MieyalJJ, YarchoanR. Thioltransferase (glutaredoxin) is detected within HIV-1 and can regulate the activity of glutathionylated HIV-1 protease in vitro. J Biol Chem, 272:25935–25940. 1997.
150.
DesseinAJ, LenziHL, BinaJC, CarvalhoEM, WeiserWY, AndradeZA, DavidJR. Modulation of eosinophil cytotoxicity by blood mononuclear cells from healthy subjects and patients with chronic schistosomiasis mansoni. Cell Immunol, 85:100–113. 1984.
151.
DeviSA, KiranTR. Regional responses in antioxidant system to exercise training and dietary vitamin E in aging rat brain. Neurobiol Aging, 25:501–508. 2004.
152.
DexterDT, HolleyAE, FlitterWD, SlaterTF, WellsFR, DanielSE, LeesAJ, JennerP, MarsdenCD. Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: an HPLC and ESR study. Mov Disord, 9:92–97. 1994.
153.
Diaz VivancosP, WolffT, MarkovicJ, PallardóFV, FoyerCH. A nuclear glutathione cycle within the cell cycle. Biochem J, 431:169–178. 2010.
154.
DingY, YamadaS, WangK-Y, ShimajiriS, GuoX, TanimotoA, MurataY, KitajimaS, WatanabeT, IzumiH, KohnoK, SasaguriY. Overexpression of peroxiredoxin 4 protects against high-dose streptozotocin-induced diabetes by suppressing oxidative stress and cytokines in transgenic mice. Antioxid Redox Signal, 13:1477–1490. 2010.
155.
DiotteNM, XiongY, GaoJ, ChuaBHL, HoY-S. Attenuation of doxorubicin-induced cardiac injury by mitochondrial glutaredoxin 2. Biochim Biophys Acta, 1793:427–438. 2009.
156.
DirnaglU, IadecolaC, MoskowitzMA. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci, 22:391–397. 1999.
157.
DistruttiE. Hydrogen sulphide and pain. Inflamm Allergy Drug Targets, 10:123–132. 2011.
158.
DittmannLM, DannerA, GronychJ, WolterM, StühlerK, GrzendowskiM, BeckerN, BageritzJ, GoidtsV, ToedtG, FelsbergJ, SabelMC, BarbusS, ReifenbergerG, LichterP, TewsB. Downregulation of PRDX1 by promoter hypermethylation is frequent in 1p/19q-deleted oligodendroglial tumours and increases radio- and chemosensitivity of Hs683 glioma cells in vitro. Oncogene, 31:3409–3418. 2012.
159.
Di DomenicoF, SultanaR, TiuGF, ScheffNN, PerluigiM, CiniC, ButterfieldDA. Protein levels of heat shock proteins 27, 32, 60, 70, 90 and thioredoxin-1 in amnestic mild cognitive impairment: an investigation on the role of cellular stress response in the progression of Alzheimer disease. Brain Res, 1333:72–81. 2010.
160.
DominyJE, StipanukMH. New roles for cysteine and transsulfuration enzymes: production of H2S, a neuromodulator and smooth muscle relaxant. Nutr Rev, 62:348–353. 2004.
161.
DrapierJC, HirlingH, WietzerbinJ, KaldyP, KühnLC. Biosynthesis of nitric oxide activates iron regulatory factor in macrophages. EMBO J, 12:3643–3649. 1993.
162.
DunnKC, Aotaki-KeenAE, PutkeyFR, HjelmelandLM. ARPE-19, a human retinal pigment epithelial cell line with differentiated properties. Exp Eye Res, 62:155–169. 1996.
163.
EglerRA, FernandesE, RothermundK, SereikaS, De Souza-PintoN, JarugaP, DizdarogluM, ProchownikEV. Regulation of reactive oxygen species, DNA damage, and c-Myc function by peroxiredoxin 1. Oncogene, 24:8038–8050. 2005.
164.
EismannT, HuberN, ShinT, KubokiS, GallowayE, WyderM, EdwardsMJ, GreisKD, ShertzerHG, FisherAB, LentschAB. Peroxiredoxin-6 protects against mitochondrial dysfunction and liver injury during ischemia-reperfusion in mice. Am J Physiol Gastrointest Liver Physiol, 296:G266–G274. 2009.
165.
EklundH, GleasonFK, HolmgrenA. Structural and functional relations among thioredoxins of different species. Proteins, 11:13–28. 1991.
166.
EltzschigHK, EckleT. Ischemia and reperfusion—from mechanism to translation. Nat Med, 17:1391–1401. 2011.
167.
EnokssonM, FernandesAP, PrastS, LilligCH, HolmgrenA, OrreniusS. Overexpression of glutaredoxin 2 attenuates apoptosis by preventing cytochrome c release. Biochem Biophys Res Commun, 327:774–779. 2005.
168.
EricksonPF, MaxwellIH, SuLJ, BaumannM, GlodeLM. Sequence of cDNA for rat cystathionine gamma-lyase and comparison of deduced amino acid sequence with related Escherichia coli enzymes. Biochem J, 269:335–340. 1990.
169.
EricsonML, HörlingJ, Wendel-HansenV, HolmgrenA, RosénA. Secretion of thioredoxin after in vitro activation of human B cells. Lymphokine Cytokine Res, 11:201–207. 1992.
170.
ErikssonS, AskelöfP, AxelssonK, CarlbergI, GuthenbergC, MannervikB. Resolution of glutathione-linked enzymes in rat liver and evaluation of their contribution to disulfide reduction via thiol—disulfide interchange. Acta Chem Scand B Org Chem Biochem, 28:922–930. 1974.
171.
EspositoF, RussoT, CiminoF. Generation of prooxidant conditions in intact cells to induce modifications of cell cycle regulatory proteins. Meth Enzymol, 352:258–268. 2002.
172.
EzashiT, DasP, RobertsRM. Low O2 tensions and the prevention of differentiation of hES cells. Proc Natl Acad Sci U S A, 102:4783–4788. 2005.
173.
FanC, ZwackaRM, EngelhardtJF. Therapeutic approaches for ischemia/reperfusion injury in the liver. J Mol Med, 77:577–592. 1999.
174.
FangJ, NakamuraT, ChoD-H, GuZ, LiptonSA. S-nitrosylation of peroxiredoxin 2 promotes oxidative stress-induced neuronal cell death in Parkinson's disease. Proc Natl Acad Sci U S A, 104:18742–18747. 2007.
175.
FangJ, ZhongL, ZhaoR, HolmgrenA. Ebselen: a thioredoxin reductase-dependent catalyst for alpha-tocopherol quinone reduction. Toxicol Appl Pharmacol, 207:103–109. 2005.
176.
FaroutL, FriguetB. Proteasome function in aging and oxidative stress: implications in protein maintenance failure. Antioxid Redox Signal, 8:205–216. 2006.
177.
FatmaN, KuboE, SenM, AgarwalN, ThoresonWB, CamrasCB, SinghDP. Peroxiredoxin 6 delivery attenuates TNF-alpha-and glutamate-induced retinal ganglion cell death by limiting ROS levels and maintaining Ca2+ homeostasis. Brain Res, 1233:63–78. 2008.
178.
FatmaN, KuboE, TorisCB, StamerWD, CamrasCB, SinghDP. PRDX6 attenuates oxidative stress- and TGFbeta-induced abnormalities of human trabecular meshwork cells. Free Radic Res, 43:783–795. 2009.
179.
FatmaN, SinghP, ChhunchhaB, KuboE, ShinoharaT, BhargavanB, SinghDP. Deficiency of Prdx6 in lens epithelial cells induces ER stress response-mediated impaired homeostasis and apoptosis. Am J Physiol Cell Physiol, 301:C954–C967. 2011.
180.
FeigeMJ, HendershotLM. Disulfide bonds in ER protein folding and homeostasis. Curr Opin Cell Biol, 23:167–175. 2011.
181.
FengY, ZhongN, RouhierN, HaseT, KusunokiM, JacquotJ-P, JinC, XiaB. Structural insight into poplar glutaredoxin C1 with a bridging iron-sulfur cluster at the active site. Biochemistry, 45:7998–8008. 2006.
182.
FentonHJH. LXXIII.-Oxidation of tartaric acid in presence of iron. J Chem Soc Trans, 65:899–910. 1894.
183.
FernandesAP, CapitanioA, SeleniusM, BrodinO, RundlöfA-K, BjörnstedtM. Expression profiles of thioredoxin family proteins in human lung cancer tissue: correlation with proliferation and differentiation. Histopathology, 55:313–320. 2009.
184.
FernandesAP, HolmgrenA. Glutaredoxins: glutathione-dependent redox enzymes with functions far beyond a simple thioredoxin backup system. Antioxid Redox Signal, 6:63–74. 2004.
185.
FernandoMR, LechnerJM, LöfgrenS, GladyshevVN, LouMF. Mitochondrial thioltransferase (glutaredoxin 2) has GSH-dependent and thioredoxin reductase-dependent peroxidase activities in vitro and in lens epithelial cells. FASEB J, 20:2645–2647. 2006.
186.
FernandoMR, NanriH, YoshitakeS, Nagata-KunoK, MinakamiS. Thioredoxin regenerates proteins inactivated by oxidative stress in endothelial cells. Eur J Biochem, 209:917–922. 1992.
187.
FernandoMR, SumimotoH, NanriH, KawabataS, IwanagaS, MinakamiS, FukumakiY, TakeshigeK. Cloning and sequencing of the cDNA encoding human glutaredoxin. Biochim Biophys Acta, 1218:229–231. 1994.
188.
FerranteRJ, BrowneSE, ShinobuLA, BowlingAC, BaikMJ, MacGarveyU, KowallNW, BrownRHJr., BealMF. Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. J Neurochem, 69:2064–2074. 1997.
189.
FerreiraLF, ReidMB. Muscle-derived ROS and thiol regulation in muscle fatigue. J Appl Physiol, 104:853–860. 2008.
190.
FerreiraNE, OmaeS, PereiraA, RodriguesMV, MiyakawaAA, CamposLCG, SantosPCJL, DallanLA, MartinezTL, SantosRD, MillJG, KriegerJE, PereiraAC. Thioredoxin interacting protein genetic variation is associated with diabetes and hypertension in the Brazilian general population. Atherosclerosis, 221:131–136. 2012.
191.
FerriA, FiorenzoP, NenciniM, CozzolinoM, PesaresiMG, ValleC, SepeS, MorenoS, CarrìMT. Glutaredoxin 2 prevents aggregation of mutant SOD1 in mitochondria and abolishes its toxicity. Hum Mol Genet, 19:4529–4542. 2010.
192.
FigueiredoPA, MotaMP, AppellHJ, DuarteJA. The role of mitochondria in aging of skeletal muscle. Biogerontology, 9:67–84. 2008.
FinkelT, HolbrookNJ. Oxidants, oxidative stress and the biology of ageing. Nature, 408:239–247. 2000.
195.
FisherAB. Peroxiredoxin 6: a bifunctional enzyme with glutathione peroxidase and phospholipase A2 activities. Antioxid Redox Signal, 15:831–844. 2011.
196.
FisherAB, DodiaC, ManevichY, ChenJW, FeinsteinSI. Phospholipid hydroperoxides are substrates for non-selenium glutathione peroxidase. J Biol Chem, 274:21326–21334. 1999.
197.
FitzgeraldLA, ZhangY, LewisG, Van EttenJL. Characterization of a monothiol glutaredoxin encoded by Chlorella virus PBCV-1. Virus Genes, 39:418–426. 2009.
198.
FitzpatrickAM, TeagueWG, HolguinF, YehM, BrownLAS. Airway glutathione homeostasis is altered in children with severe asthma: evidence for oxidant stress. J Allergy Clin Immunol, 123:146–152.e8. 2009.
199.
FlohéL, ToppoS, CozzaG, UrsiniF. A comparison of thiol peroxidase mechanisms. Antioxid Redox Signal, 15:763–780. 2011.
ForouzanniaA, RichardsGM, KhuntiaD, MehtaMP. Motexafin gadolinium: a novel radiosensitizer for brain tumors. Expert Rev Anticancer Ther, 7:785–794. 2007.
202.
FosterMW, ForresterMT, StamlerJS. A protein microarray-based analysis of S-nitrosylation. Proc Natl Acad Sci U S A, 106:18948–18953. 2009.
203.
FosterMW, HessDT, StamlerJS. Protein S-nitrosylation in health and disease: a current perspective. Trends Mol Med, 15:391–404. 2009.
204.
FrancoleonNE, CarringtonSJ, FukutoJM. The reaction of H(2)S with oxidized thiols: generation of persulfides and implications to H(2)S biology. Arch Biochem Biophys, 516:146–153. 2011.
205.
FratelliM, GianazzaE, GhezziP. Redox proteomics: identification and functional role of glutathionylated proteins. Expert Rev Proteomics, 1:365–376. 2004.
206.
FreemermanAJ, GallegosA, PowisG. Nuclear factor kappaB transactivation is increased but is not involved in the proliferative effects of thioredoxin overexpression in MCF-7 breast cancer cells. Cancer Res, 59:4090–4094. 1999.
207.
Freiesleben De BlasioB, BakP, PociotF, KarlsenAE, NerupJ. Onset of type 1 diabetes: a dynamical instability. Diabetes, 48:1677–1685. 1999.
208.
FridovichI. Quantitative aspects of the production of superoxide anion radical by milk xanthine oxidase. J Biol Chem, 245:4053–4057. 1970.
209.
FryM, GreenDE. Cardiolipin requirement for electron transfer in complex I and III of the mitochondrial respiratory chain. J Biol Chem, 256:1874–1880. 1981.
210.
FujiiJ, IuchiY, OkadaF. Fundamental roles of reactive oxygen species and protective mechanisms in the female reproductive system. Reprod Biol Endocrinol, 3:43. 2005.
211.
FujiiT, FujiiJ, TaniguchiN. Augmented expression of peroxiredoxin VI in rat lung and kidney after birth implies an antioxidative role. Eur J Biochem, 268:218–225. 2001.
212.
FukaiT, Ushio-FukaiM. Superoxide dismutases: role in redox signaling, vascular function, and diseases. Antioxid Redox Signal, 15:1583–1606. 2011.
213.
FunatoY, MichiueT, AsashimaM, MikiH. The thioredoxin-related redox-regulating protein nucleoredoxin inhibits Wnt-beta-catenin signalling through dishevelled. Nat Cell Biol, 8:501–508. 2006.
214.
FunatoY, MichiueT, TerabayashiT, YukitaA, DannoH, AsashimaM, MikiH. Nucleoredoxin regulates the Wnt/planar cell polarity pathway in Xenopus. Genes Cells, 13:965–975. 2008.
215.
FunatoY, MikiH. Nucleoredoxin, a novel thioredoxin family member involved in cell growth and differentiation. Antioxid Redox Signal, 9:1035–1057. 2007.
216.
FunatoY, TerabayashiT, SakamotoR, OkuzakiD, IchiseH, NojimaH, YoshidaN, MikiH. Nucleoredoxin sustains Wnt/β-catenin signaling by retaining a pool of inactive dishevelled protein. Curr Biol, 20:1945–1952. 2010.
217.
FurchgottRF. Endothelium-derived relaxing factor: discovery, early studies, and identification as nitric oxide. Biosci Rep, 19:235–251. 1999.
218.
GalloglyMM, StarkeDW, LeonbergAK, OspinaSME, MieyalJJ. Kinetic and mechanistic characterization and versatile catalytic properties of mammalian glutaredoxin 2: implications for intracellular roles. Biochemistry, 47:11144–11157. 2008.
219.
GaoB-B, ChenX, TimothyN, AielloLP, FeenerEP. Characterization of the vitreous proteome in diabetes without diabetic retinopathy and diabetes with proliferative diabetic retinopathy. J Proteome Res, 7:2516–2525. 2008.
220.
García-PardoL, GranadosMD, GaytánF, PadillaCA, Martínez-GalisteoE, MoralesC, Sánchez-CriadoJE, BárcenaJA. Immunolocalization of glutaredoxin in the human corpus luteum. Mol Hum Reprod, 5:914–919. 1999.
221.
GardinerCS, ReedDJ. Status of glutathione during oxidant-induced oxidative stress in the preimplantation mouse embryo. Biol Reprod, 51:1307–1314. 1994.
222.
GasdaskaPY, OblongJE, CotgreaveIA, PowisG. The predicted amino acid sequence of human thioredoxin is identical to that of the autocrine growth factor human adult T-cell derived factor (ADF): thioredoxin mRNA is elevated in some human tumors. Biochim Biophys Acta, 1218:292–296. 1994.
223.
Geiben-LynnR, KursarM, BrownNV, AddoMM, ShauH, LiebermanJ, LusterAD, WalkerBD. HIV-1 antiviral activity of recombinant natural killer cell enhancing factors, NKEF-A and NKEF-B, members of the peroxiredoxin family. J Biol Chem, 278:1569–1574. 2003.
GertzM, FischerF, WoltersD, SteegbornC. Activation of the lifespan regulator p66Shc through reversible disulfide bond formation. Proc Natl Acad Sci U S A, 105:5705–5709. 2008.
226.
GertzM, SteegbornC. The Lifespan-regulator p66Shc in mitochondria: redox enzyme or redox sensor?Antioxid Redox Signal, 13:1417–1428. 2010.
227.
GhezziP, BonettoV, FratelliM. Thiol-disulfide balance: from the concept of oxidative stress to that of redox regulation. Antioxid Redox Signal, 7:964–972. 2005.
228.
GibsonKR, WinterburnTJ, BarrettF, SharmaS, MacRurySM, MegsonIL. Therapeutic potential of N-acetylcysteine as an antiplatelet agent in patients with type-2 diabetes. Cardiovasc Diabetol, 10:43. 2011.
229.
GilesGI. The redox regulation of thiol dependent signaling pathways in cancer. Curr Pharm Des, 12:4427–4443. 2006.
230.
GilL, MartínezG, GonzálezI, TarinasA, AlvarezA, GiulianiA, MolinaR, TápanesR, PérezJ, LeónOS. Contribution to characterization of oxidative stress in HIV/AIDS patients. Pharmacol Res, 47:217–224. 2003.
GilmanAG. Nobel Lecture. G proteins and regulation of adenylyl cyclase. Biosci Rep, 15:65–97. 1995.
233.
GiustariniD, MilzaniA, AldiniG, CariniM, RossiR, Dalle-DonneI. S-nitrosation versus S-glutathionylation of protein sulfhydryl groups by S-nitrosoglutathione. Antioxid Redox Signal, 7:930–939. 2005.
234.
GobeGC, JohnsonDW. Distal tubular epithelial cells of the kidney: potential support for proximal tubular cell survival after renal injury. Int J Biochem Cell Biol, 39:1551–1561. 2007.
235.
GodoyJR, FunkeM, AckermannW, HaunhorstP, OesteritzS, CapaniF, ElsässerH-P, LilligCH. Redox atlas of the mouse. Immunohistochemical detection of glutaredoxin-, peroxiredoxin-, and thioredoxin-family proteins in various tissues of the laboratory mouse. Biochim Biophys Acta, 1810:2–92. 2011.
236.
GodoyJR, OesteritzS, HanschmannE-M, OckengaW, AckermannW, LilligCH. Segment-specific overexpression of redoxins after renal ischemia and reperfusion: protective roles of glutaredoxin 2, peroxiredoxin 3, and peroxiredoxin 6. Free Radic Biol Med, 51:552–561. 2011.
237.
González-FernándezR, GaytánF, Martínez-GalisteoE, PorrasP, PadillaCA, Sánchez CriadoJE, BárcenaJA. Expression of glutaredoxin (thioltransferase) in the rat ovary during the oestrous cycle and postnatal development. J Mol Endocrinol, 34:625–635. 2005.
238.
GougeonM-L. Apoptosis as an HIV strategy to escape immune attack. Nat Rev Immunol, 3:392–404. 2003.
GrimsrudPA, XieH, GriffinTJ, BernlohrDA. Oxidative stress and covalent modification of protein with bioactive aldehydes. J Biol Chem, 283:21837–21841. 2008.
243.
GroganTM, Fenoglio-PrieserC, ZehebR, BellamyW, FrutigerY, VelaE, StemmermanG, MacdonaldJ, RichterL, GallegosA, PowisG. Thioredoxin, a putative oncogene product, is overexpressed in gastric carcinoma and associated with increased proliferation and increased cell survival. Hum Pathol, 31:475–481. 2000.
244.
GruberCW, CemazarM, HerasB, MartinJL, CraikDJ. Protein disulfide isomerase: the structure of oxidative folding. Trends Biochem Sci, 31:455–464. 2006.
245.
GruetterCA, BarryBK, McNamaraDB, GruetterDY, KadowitzPJ, IgnarroL. Relaxation of bovine coronary artery and activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside and a carcinogenic nitrosoamine. J Cyclic Nucleotide Res, 5:211–224. 1979.
246.
GrunewaldRW, WeberII, Kinne-SaffranE, KinneRK. Control of sorbitol metabolism in renal inner medulla of diabetic rats: regulation by substrate, cosubstrate and products of the aldose reductase reaction. Biochim Biophys Acta, 1225:39–47. 1993.
247.
Del GuerraS, LupiR, MarselliL, MasiniM, BuglianiM, SbranaS, TorriS, PolleraM, BoggiU, MoscaF, Del PratoS, MarchettiP. Functional and molecular defects of pancreatic islets in human type 2 diabetes. Diabetes, 54:727–735. 2005.
248.
GuoQ, HuangX, ZhangJ, LuoY, PengZ, LiS. Downregulation of peroxiredoxin I by a novel fully human phage display recombinant antibody induces apoptosis and enhances radiation sensitization in A549 lung carcinoma cells. Cancer Biother Radiopharm, 27:307–316. 2012.
249.
HaberF, WilstätterR. Unpaarigheit und Radikalketten im Reaktion-Mechanismus organischer und enzymatischer Vorgänge. Chem Ber, 64:2844–2856. 1931.
250.
HaciogluE, EsmerI, FomenkoDE, GladyshevVN, KocA. The roles of thiol oxidoreductases in yeast replicative aging. Mech Ageing Dev, 131:692–699. 2010.
251.
HackettNR, HeguyA, HarveyB-G, O'ConnorTP, LuettichK, FliederDB, KaplanR, CrystalRG. Variability of antioxidant-related gene expression in the airway epithelium of cigarette smokers. Am J Respir Cell Mol Biol, 29:331–343. 2003.
252.
HainautP, MilnerJ. Redox modulation of p53 conformation and sequence-specific DNA binding in vitro. Cancer Res, 53:4469–4473. 1993.
253.
HalliwellB, GutteridgeJM. The antioxidants of human extracellular fluids. Arch Biochem Biophys, 280:1–8. 1990.
HamadaY, FujiiH, KitazawaR, YodoiJ, KitazawaS, FukagawaM. Thioredoxin-1 overexpression in transgenic mice attenuates streptozotocin-induced diabetic osteopenia: a novel role of oxidative stress and therapeutic implications. Bone, 44:936–941. 2009.
256.
HamadaY, MiyataS, Nii-KonoT, KitazawaR, KitazawaS, HigoS, FukunagaM, UeyamaS, NakamuraH, YodoiJ, FukagawaM, KasugaM. Overexpression of thioredoxin1 in transgenic mice suppresses development of diabetic nephropathy. Nephrol Dial Transplant, 22:1547–1557. 2007.
257.
Hamnell-PammentY, LindC, PalmbergC, BergmanT, CotgreaveIA. Determination of site-specificity of S-glutathionylated cellular proteins. Biochem Biophys Res Commun, 332:362–369. 2005.
258.
HanschmannE-M, LönnME, SchütteLD, FunkeM, GodoyJR, EitnerS, HudemannC, LilligCH. Both thioredoxin 2 and glutaredoxin 2 contribute to the reduction of the mitochondrial 2-cys peroxiredoxin prx3. J Biol Chem, 285:40699–40705. 2010.
259.
HanssonHA, HolmgrenA, NorstedtG, RozellB. Changes in the distribution of insulin-like growth factor I, thioredoxin, thioredoxin reductase and ribonucleotide reductase during the development of the retina. Exp Eye Res, 48:411–420. 1989.
260.
HanssonHA, HolmgrenA, RozellB, TäljedalIB. Immunohistochemical localization of thioredoxin and thioredoxin reductase in mouse exocrine and endocrine pancreas. Cell Tissue Res, 245:189–195. 1986.
261.
HarjuT, Kaarteenaho-WiikR, SoiniY, SormunenR, KinnulaVL. Diminished immunoreactivity of gamma-glutamylcysteine synthetase in the airways of smokers' lung. Am J Respir Crit Care Med, 166:754–759. 2002.
262.
HarmanD. Aging: a theory based on free radical and radiation chemistry. J Gerontol, 11:298–300. 1956.
263.
HarmanD. The biologic clock: the mitochondria?J Am Geriatr Soc, 20:145–147. 1972.
HarrisJR. Release of a macromolecular protein component from human erythrocyte ghosts. Biochim Biophys Acta, 150:534–537. 1968.
266.
HasanovaN, KuboE, KumamotoY, TakamuraY, AkagiY. Age-related cataracts and Prdx6: correlation between severity of lens opacity, age and the level of Prdx 6 expression. Br J Ophthalmol, 93:1081–1084. 2009.
267.
HasegawaA, SuzukiS, MatsumotoY, OkuboT. In vivo fatiguing contraction of rat diaphragm produces hydroxyl radicals. Free Radic Biol Med, 22:349–354. 1997.
268.
HashemySI, UngerstedtJS, Zahedi AvvalF, HolmgrenA. Motexafin gadolinium, a tumor-selective drug targeting thioredoxin reductase and ribonucleotide reductase. J Biol Chem, 281:10691–10697. 2006.
269.
HattoriI, TakagiY, NakamuraH, NozakiK, BaiJ, KondoN, SuginoT, NishimuraM, HashimotoN, YodoiJ. Intravenous administration of thioredoxin decreases brain damage following transient focal cerebral ischemia in mice. Antioxid Redox Signal, 6:81–87. 2004.
270.
HatzopoulosAK, De AngelisMH, WurstW, BornkammGW, BrielmeierM, ConradM, JakupogluC, PrzemeckGKH, SchneiderM, MorenoSG, MayrN. Cytoplasmic thioredoxin reductase is essential for embryogenesis but dispensable for cardiac development. Mol Cell Biol, 25:1980–1988. 2005.
271.
HaunhorstP, BerndtC, EitnerS, GodoyJR, LilligCH. Characterization of the human monothiol glutaredoxin 3 (PICOT) as iron-sulfur protein. Biochem Biophys Res Commun, 394:372–376. 2010.
HegdeA, BhatiaM. Hydrogen sulfide in inflammation: friend or foe?Inflamm Allergy Drug Targets, 10:118–122. 2011.
275.
HellbergV, WallinI, ErikssonS, HernlundE, JerremalmE, BerndtssonM, EksborgS, ArnérESJ, ShoshanM, EhrssonH, LaurellG. Cisplatin and oxaliplatin toxicity: importance of cochlear kinetics as a determinant for ototoxicity. J Natl Cancer Inst, 101:37–47. 2009.
276.
HentzeMW, MuckenthalerMU, AndrewsNC. Balancing acts: molecular control of mammalian iron metabolism. Cell, 117:285–297. 2004.
277.
HerreroE, De la Torre-RuizMA. Monothiol glutaredoxins: a common domain for multiple functions. Cell Mol Life Sci, 64:1518–1530. 2007.
278.
HessDT, MatsumotoA, KimS-O, MarshallHE, StamlerJS. Protein S-nitrosylation: purview and parameters. Nat Rev Mol Cell Biol, 6:150–166. 2005.
279.
HirotaK, MatsuiM, MurataM, TakashimaY, ChengFS, ItohT, FukudaK, YodoiJ, JunjiY. Nucleoredoxin, glutaredoxin, and thioredoxin differentially regulate NF-kappaB, AP-1, and CREB activation in HEK293 cells. Biochem Biophys Res Commun, 274:177–182. 2000.
280.
HirotaK, MurataM, SachiY, NakamuraH, TakeuchiJ, MoriK, YodoiJ. Distinct roles of thioredoxin in the cytoplasm and in the nucleus. A two-step mechanism of redox regulation of transcription factor NF-kappaB. J Biol Chem, 274:27891–27897. 1999.
281.
HirotaK, NakamuraH, MasutaniH, YodoiJ. Thioredoxin superfamily and thioredoxin-inducing agents. Ann N Y Acad Sci, 957:189–199. 2002.
282.
HochFL. Cardiolipins and biomembrane function. Biochim Biophys Acta, 1113:71–133. 1992.
HolmgrenA. Thioredoxin. 6. The amino acid sequence of the protein from escherichia coli B. Eur J Biochem, 6:475–484. 1968.
285.
HolmgrenA. Hydrogen donor system for Escherichia coli ribonucleoside-diphosphate reductase dependent upon glutathione. Proc Natl Acad Sci U S A, 73:2275–2279. 1976.
286.
HolmgrenA. Glutathione-dependent enzyme reactions of the phage T4 ribonucleotide reductase system. J Biol Chem, 253:7424–7430. 1978.
287.
HolmgrenA. Glutathione-dependent synthesis of deoxyribonucleotides. Purification and characterization of glutaredoxin from Escherichia coli. J Biol Chem, 254:3664–3671. 1979.
288.
HolmgrenA. Glutathione-dependent synthesis of deoxyribonucleotides. Characterization of the enzymatic mechanism of Escherichia coli glutaredoxin. J Biol Chem, 254:3672–3678. 1979.
HolmgrenA, BjörnstedtM. Thioredoxin and thioredoxin reductase. Meth Enzymol, 252:199–208. 1995.
291.
HolmgrenA, BuchananBB, WolosiukRA. Photosynthetic regulatory protein from rabbit liver is identical with thioredoxin. FEBS Lett, 82:351–354. 1977.
292.
HolmgrenA, LuthmanM. Tissue distrubution and subcellular localization of bovine thioredoxin determined by radioimmunoassay. Biochemistry, 17:4071–4077. 1978.
293.
HolmgrenA, SöderbergBO, EklundH, BrändénCI. Three-dimensional structure of Escherichia coli thioredoxin-S2 to 2.8 A resolution. Proc Natl Acad Sci U S A, 72:2305–2309. 1975.
294.
HopkinsFG. On an autoxidisable constituent of the cell. Biochem J, 15:286–305. 1921.
295.
HopkinsFG. On the isolation of glutathione. J Biol Chem, 72:185–187. 1927.
296.
HopkinsFG, DixonM. On glutathione. J Biol Chem, 54:527–563. 1922.
297.
HopkinsFG, With a section in the text by LeslieJ. Harris. On glutathione: a reinvestigation. J Biol Chem, 84:269–320. 1929.
HoskinsER, HoodBL, SunM, KrivakTC, EdwardsRP, ConradsTP. Proteomic analysis of ovarian cancer proximal fluids: validation of elevated peroxiredoxin 1 in patient peripheral circulation. PLoS One, 6:e25056. 2011.
300.
HottaM, TashiroF, IkegamiH, NiwaH, OgiharaT, YodoiJ, MiyazakiJ. Pancreatic beta cell-specific expression of thioredoxin, an antioxidative and antiapoptotic protein, prevents autoimmune and streptozotocin-induced diabetes. J Exp Med, 188:1445–1451. 1998.
301.
HoY-S, XiongY, HoDS, GaoJ, ChuaBHL, PaiH, MieyalJJ. Targeted disruption of the glutaredoxin 1 gene does not sensitize adult mice to tissue injury induced by ischemia/reperfusion and hyperoxia. Free Radic Biol Med, 43:1299–1312. 2007.
302.
HsiehC-C, PapaconstantinouJ. The effect of aging on p38 signaling pathway activity in the mouse liver and in response to ROS generated by 3-nitropropionic acid. Mech Ageing Dev, 123:1423–1435. 2002.
303.
HsiehC-C, RosenblattJI, PapaconstantinouJ. Age-associated changes in SAPK/JNK and p38 MAPK signaling in response to the generation of ROS by 3-nitropropionic acid. Mech Ageing Dev, 124:733–746. 2003.
304.
HsuH-H, HoffmannS, Di MarcoGS, EndlichN, Peter-KatalinićJ, WeideT, PavenstädtH. Downregulation of the antioxidant protein peroxiredoxin 2 contributes to angiotensin II-mediated podocyte apoptosis. Kidney Int, 80:959–969. 2011.
305.
HsuM, SrinivasB, KumarJ, SubramanianR, AndersenJ. Glutathione depletion resulting in selective mitochondrial complex I inhibition in dopaminergic cells is via an NO-mediated pathway not involving peroxynitrite: implications for Parkinson's disease. J Neurochem, 92:1091–1103. 2005.
306.
HuangC-F, SunZ-J, ZhaoY-F, ChenX-M, JiaJ, ZhangW-F. Increased expression of peroxiredoxin 6 and cyclophilin A in squamous cell carcinoma of the tongue. Oral Dis, 17:328–334. 2011.
307.
HuangZ, PintoJT, DengH, RichieJPJr. Inhibition of caspase-3 activity and activation by protein glutathionylation. Biochem Pharmacol, 75:2234–2244. 2008.
308.
HuberHE, TaborS, RichardsonCC. Escherichia coli thioredoxin stabilizes complexes of bacteriophage T7 DNA polymerase and primed templates. J Biol Chem, 262:16224–16232. 1987.
309.
HudemannC, BerndtC, LilligCH. Glutaredoxine und Eisen-Schwefel-Zentren. Biospektrum, 14:32–35. 2008.
HughesMN, CentellesMN, MooreKP. Making and working with hydrogen sulfide: the chemistry and generation of hydrogen sulfide in vitro and its measurement in vivo: a review. Free Radic Biol Med, 47:1346–1353. 2009.
312.
HuH, LuL, MuW, JohnsonRJ, BlockER, PatelJM. Priming donor lungs with thioredoxin-1 attenuates acute allograft injury in a rat model of lung transplantation. J Heart Lung Transplant, 27:1142–1149. 2008.
313.
HunterG, EaglesBA. Non-protein sulfur compounds of the blood. J Biol Chem, 72:133–146. 1927.
314.
HutchensMP, DunlapJ, HurnPD, JarnbergPO. Renal ischemia: does sex matter?Anesth Analg, 107:239–249. 2008.
315.
HuX, WengZ, ChuCT, ZhangL, CaoG, GaoY, SignoreA, ZhuJ, HastingsT, GreenamyreJT, ChenJ. Peroxiredoxin-2 protects against 6-hydroxydopamine-induced dopaminergic neurodegeneration via attenuation of the apoptosis signal-regulating kinase (ASK1) signaling cascade. J Neurosci, 31:247–261. 2011.
316.
HwangIK, YooK-Y, KimDW, LeeCH, ChoiJH, KwonY-G, KimY-M, ChoiSY, WonM-H. Changes in the expression of mitochondrial peroxiredoxin and thioredoxin in neurons and glia and their protective effects in experimental cerebral ischemic damage. Free Radic Biol Med, 48:1242–1251. 2010.
317.
IchijoH, NishidaE, IrieK, Ten DijkeP, SaitohM, MoriguchiT, TakagiM, MatsumotoK, MiyazonoK, GotohY. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science, 275:90–94. 1997.
318.
IchikiH, HoshinoT, KinoshitaT, ImaokaH, KatoS, InoueH, NakamuraH, YodoiJ, YoungHA, AizawaH. Thioredoxin suppresses airway hyperresponsiveness and airway inflammation in asthma. Biochem Biophys Res Commun, 334:1141–1148. 2005.
319.
IkegamiH, OnoM, FujisawaT, HiromineY, KawabataY, YamatoE. Molecular scanning of the gene for thioredoxin, an antioxidative and antiapoptotic protein, and genetic susceptibility to type 1 diabetes. Ann N Y Acad Sci, 1150:103–105. 2008.
320.
ImJ-Y, LeeK-W, WooJ-M, JunnE, MouradianMM. DJ-1 induces thioredoxin 1 expression through the Nrf2 pathway. Hum Mol Genet, 21:3013–3024. 2012.
321.
ImmenschuhS, Baumgart-VogtE, TanM, IwaharaS, RamadoriG, FahimiHD. Differential cellular and subcellular localization of heme-binding protein 23/peroxiredoxin I and heme oxygenase-1 in rat liver. J Histochem Cytochem, 51:1621–1631. 2003.
322.
ImmerFF, LippeckC, BarmettlerH, BerdatPA, EcksteinFS, KipferB, SanerH, SchmidliJ, CarrelTP. Improvement of quality of life after surgery on the thoracic aorta: effect of antegrade cerebral perfusion and short duration of deep hypothermic circulatory arrest. Circulation, 110:II250–II255. 2004.
323.
InomataY, NakamuraH, TanitoM, TerataniA, KawajiT, KondoN, YodoiJ, TaniharaH. Thioredoxin inhibits NMDA-induced neurotoxicity in the rat retina. J Neurochem, 98:372–385. 2006.
324.
InoueK, TakanoH, KoikeE, WarabiE, YanagawaT, YanagisawaR, IshiiT. Peroxiredoxin I is a negative regulator of Th2-dominant allergic asthma. Int Immunopharmacol, 9:1281–1288. 2009.
IshiiT, YamadaM, SatoH, MatsueM, TaketaniS, NakayamaK, SugitaY, BannaiS. Cloning and characterization of a 23-kDa stress-induced mouse peritoneal macrophage protein. J Biol Chem, 268:18633–18636. 1993.
327.
ItoW, KobayashiN, TakedaM, UekiS, KayabaH, NakamuraH, YodoiJ, ChiharaJ. Thioredoxin in allergic inflammation. Int Arch Allergy Immunol, 155,Suppl 1:142–146. 2011.
328.
IuchiY, OkadaF, TsunodaS, KibeN, ShirasawaN, IkawaM, OkabeM, IkedaY, FujiiJ. Peroxiredoxin 4 knockout results in elevated spermatogenic cell death via oxidative stress. Biochem J, 419:149–158. 2009.
329.
IvarssonR, QuintensR, DejongheS, TsukamotoK, In't VeldP, RenströmE, SchuitFC. Redox control of exocytosis: regulatory role of NADPH, thioredoxin, and glutaredoxin. Diabetes, 54:2132–2142. 2005.
330.
IversonSL, OrreniusS. The cardiolipin-cytochrome c interaction and the mitochondrial regulation of apoptosis. Arch Biochem Biophys, 423:37–46. 2004.
JewellUR, KvietikovaI, ScheidA, BauerC, WengerRH, GassmannM. Induction of HIF-1alpha in response to hypoxia is instantaneous. FASEB J, 15:1312–1314. 2001.
340.
JhaN, JurmaO, LalliG, LiuY, PettusEH, GreenamyreJT, LiuRM, FormanHJ, AndersenJK. Glutathione depletion in PC12 results in selective inhibition of mitochondrial complex I activity. Implications for Parkinson's disease. J Biol Chem, 275:26096–26101. 2000.
341.
JiaL, BonaventuraC, BonaventuraJ, StamlerJS. S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature, 380:221–226. 1996.
342.
JikimotoT, NishikuboY, KoshibaM, KanagawaS, MorinobuS, MorinobuA, SauraR, MizunoK, KondoS, ToyokuniS, NakamuraH, YodoiJ, KumagaiS. Thioredoxin as a biomarker for oxidative stress in patients with rheumatoid arthritis. Mol Immunol, 38:765–772. 2002.
343.
JiménezA, JohanssonC, LjungJ, SagemarkJ, BerndtKD, RenB, TibbelinG, LadensteinR, KieselbachT, HolmgrenA, GustafssonJA, Miranda-VizueteA. Human spermatid-specific thioredoxin-1 (Sptrx-1) is a two-domain protein with oxidizing activity. FEBS Lett, 530:79–84. 2002.
344.
JiménezA, Pelto-HuikkoM, GustafssonJ-A, Miranda-VizueteA. Characterization of human thioredoxin-like-1: potential involvement in the cellular response against glucose deprivation. FEBS Lett, 580:960–967. 2006.
345.
JiménezA, ZuW, RaweVY, Pelto-HuikkoM, FlickingerCJ, SutovskyP, GustafssonJ-A, OkoR, Miranda-VizueteA. Spermatocyte/spermatid-specific thioredoxin-3, a novel Golgi apparatus-associated thioredoxin, is a specific marker of aberrant spermatogenesis. J Biol Chem, 279:34971–34982. 2004.
346.
JinDY, ChaeHZ, RheeSG, JeangKT. Regulatory role for a novel human thioredoxin peroxidase in NF-kappaB activation. J Biol Chem, 272:30952–30961. 1997.
347.
JinM-H, LeeY-H, KimJ-M, SunH-N, MoonE-Y, ShongMH, KimS-U, LeeSH, LeeT-H, YuD-Y, LeeD-S. Characterization of neural cell types expressing peroxiredoxins in mouse brain. Neurosci Lett, 381:252–257. 2005.
348.
JohanssonC, KavanaghKL, GileadiO, OppermannU. Reversible sequestration of active site cysteines in a 2Fe-2S-bridged dimer provides a mechanism for glutaredoxin 2 regulation in human mitochondria. J Biol Chem, 282:3077–3082. 2007.
349.
JohanssonC, LilligCH, HolmgrenA. Human mitochondrial glutaredoxin reduces S-glutathionylated proteins with high affinity accepting electrons from either glutathione or thioredoxin reductase. J Biol Chem, 279:7537–7543. 2004.
350.
JohanssonC, RoosAK, MontanoSJ, SenguptaR, FilippakopoulosP, GuoK, Von DelftF, HolmgrenA, OppermannU, KavanaghKL. The crystal structure of human GLRX5: iron-sulfur cluster co-ordination, tetrameric assembly and monomer activity. Biochem J, 433:303–311. 2011.
351.
JohnstonMV, TrescherWH, IshidaA, NakajimaW. Neurobiology of hypoxic-ischemic injury in the developing brain. Pediatr Res, 49:735–741. 2001.
352.
JomovaK, ValkoM. Advances in metal-induced oxidative stress and human disease. Toxicology, 283:65–87. 2011.
353.
JonesDP. Redox potential of GSH/GSSG couple: assay and biological significance. Meth Enzymol, 348:93–112. 2002.
JönssonTJ, MurrayMS, JohnsonLC, LowtherWT. Reduction of cysteine sulfinic acid in peroxiredoxin by sulfiredoxin proceeds directly through a sulfinic phosphoryl ester intermediate. J Biol Chem, 283:23846–23851. 2008.
356.
JönssonTJ, TsangAW, LowtherWT, FurduiCM. Identification of intact protein thiosulfinate intermediate in the reduction of cysteine sulfinic acid in peroxiredoxin by human sulfiredoxin. J Biol Chem, 283:22890–22894. 2008.
357.
JørgensenMC, Ahnfelt-RønneJ, HaldJ, MadsenOD, SerupP, Hecksher-SørensenJ. An illustrated review of early pancreas development in the mouse. Endocr Rev, 28:685–705. 2007.
358.
JoubertJ, MalanSF. Novel nitric oxide synthase inhibitors: a patent review. Expert Opin Ther Pat, 21:537–560. 2011.
359.
JuradoJ, Prieto-AlamoM-J, Madrid-RísquezJ, PueyoC. Absolute gene expression patterns of thioredoxin and glutaredoxin redox systems in mouse. J Biol Chem, 278:45546–45554. 2003.
360.
KaarnirantaK, SalminenA, HaapasaloA, SoininenH, HiltunenM. Age-related macular degeneration (AMD): Alzheimer's disease in the eye?J Alzheimers Dis, 24:615–631. 2011.
361.
Kaarteenaho-WiikR, KinnulaVL. Distribution of antioxidant enzymes in developing human lung, respiratory distress syndrome, and bronchopulmonary dysplasia. J Histochem Cytochem, 52:1231–1240. 2004.
362.
KaimulAM, NakamuraH, MasutaniH, YodoiJ. Thioredoxin and thioredoxin-binding protein-2 in cancer and metabolic syndrome. Free Radic Biol Med, 43:861–868. 2007.
363.
KakisakaY, NakashimaT, SumidaY, YohT, NakamuraH, YodoiJ, SenmaruH. Elevation of serum thioredoxin levels in patients with type 2 diabetes. Horm Metab Res, 34:160–164. 2002.
364.
KalantariP, NarayanV, NatarajanSK, MuralidharK, GandhiUH, VuntaH, HendersonAJ, PrabhuKS. Thioredoxin reductase-1 negatively regulates HIV-1 transactivating protein Tat-dependent transcription in human macrophages. J Biol Chem, 283:33183–33190. 2008.
365.
KamimotoY, SugiyamaT, KihiraT, ZhangL, MurabayashiN, UmekawaT, NagaoK, MaN, ToyodaN, YodoiJ, SagawaN. Transgenic mice overproducing human thioredoxin-1, an antioxidative and anti-apoptotic protein, prevents diabetic embryopathy. Diabetologia, 53:2046–2055. 2010.
366.
KanetoH, FujiiJ, MyintT, MiyazawaN, IslamKN, KawasakiY, SuzukiK, NakamuraM, TatsumiH, YamasakiY, TaniguchiN. Reducing sugars trigger oxidative modification and apoptosis in pancreatic beta-cells by provoking oxidative stress through the glycation reaction. Biochem J, 320:855–863. 1996.
367.
KanetoH, XuG, SongKH, SuzumaK, Bonner-WeirS, SharmaA, WeirGC. Activation of the hexosamine pathway leads to deterioration of pancreatic beta-cell function through the induction of oxidative stress. J Biol Chem, 276:31099–31104. 2001.
368.
KangDH, LeeDJ, LeeKW, ParkYS, LeeJY, LeeS-H, KohYJ, KohG-Y, ChoiC, YuD-Y, KimJ, KangSW. Peroxiredoxin II is an essential antioxidant enzyme that prevents the oxidative inactivation of VEGF receptor-2 in vascular endothelial cells. Mol Cell, 44:545–558. 2011.
369.
KangSW, ShinH-S, LeeK-K, RheeSG, YuD-Y, LeeT-H, KimS-U, YuS-L, KimSH, ParkDS, MoonH-B, DhoSH, KwonK-S, KwonHJ, HanY-H, JeongS. Peroxiredoxin II is essential for sustaining life span of erythrocytes in mice. Blood, 101:5033–5038. 2003.
370.
KarihtalaP, SoiniY, VaskivuoL, BloiguR, PuistolaU. DNA adduct 8-hydroxydeoxyguanosine, a novel putative marker of prognostic significance in ovarian carcinoma. Int J Gynecol Cancer, 19:1047–1051. 2009.
371.
KarunakaranS, SaeedU, RamakrishnanS, KoumarRC, RavindranathV. Constitutive expression and functional characterization of mitochondrial glutaredoxin (Grx2) in mouse and human brain. Brain Res, 1185:8–17. 2007.
372.
KasunoK, NakamuraH, OnoT, MusoE, YodoiJ. Protective roles of thioredoxin, a redox-regulating protein, in renal ischemia/reperfusion injury. Kidney Int, 64:1273–1282. 2003.
373.
KatoN, MotohashiS, OkadaT, OzawaT, MashimaK. PICOT, protein kinase C theta-interacting protein, is a novel regulator of FcepsilonRI-mediated mast cell activation. Cell Immunol, 251:62–67. 2008.
374.
KatoS, KatoM, AbeY, MatsumuraT, NishinoT, AokiM, ItoyamaY, AsayamaK, AwayaA, HiranoA, OhamaE. Redox system expression in the motor neurons in amyotrophic lateral sclerosis (ALS): immunohistochemical studies on sporadic ALS, superoxide dismutase 1 (SOD1)-mutated familial ALS, and SOD1-mutated ALS animal models. Acta Neuropathol, 110:101–112. 2005.
375.
KawahitoS, KitahataH, OshitaS. Problems associated with glucose toxicity: role of hyperglycemia-induced oxidative stress. World J Gastroenterol, 15:4137–4142. 2009.
376.
KenchappaRS, RavindranathV. Glutaredoxin is essential for maintenance of brain mitochondrial complex I: studies with MPTP. FASEB J, 17:717–719. 2003.
377.
KettenhofenNJ, WoodMJ. Formation, reactivity, and detection of protein sulfenic acids. Chem Res Toxicol, 23:1633–1646. 2010.
378.
KimHS, KangSW, RheeSG, ClerchLB. Rat lung peroxiredoxins I and II are differentially regulated during development and by hyperoxia. Am J Physiol Lung Cell Mol Physiol, 280:L1212–L1217. 2001.
379.
KimH-S, ManevichY, FeinsteinSI, PakJH, HoYS, FisherAB. Induction of 1-cys peroxiredoxin expression by oxidative stress in lung epithelial cells. Am J Physiol Lung Cell Mol Physiol, 285:L363–L369. 2003.
380.
KimK, KimIH, LeeKY, RheeSG, StadtmanER. The isolation and purification of a specific “protector” protein which inhibits enzyme inactivation by a thiol/Fe(III)/O2 mixed-function oxidation system. J Biol Chem, 263:4704–4711. 1988.
381.
KimSH, FountoulakisM, CairnsN, LubecG. Protein levels of human peroxiredoxin subtypes in brains of patients with Alzheimer's disease and Down syndrome. J Neural Transm Suppl, 223–235. 2001.
382.
KimuraH. Hydrogen sulfide: its production, release and functions. Amino Acids, 41:113–121. 2011.
383.
KimuraH, WeiszA, KurashimaY, HashimotoK, OguraT, D'AcquistoF, AddeoR, MakuuchiM, EsumiH. Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: control of hypoxia-inducible factor-1 activity by nitric oxide. Blood, 95:189–197. 2000.
384.
KimYC, MasutaniH, YamaguchiY, ItohK, YamamotoM, YodoiJ. Hemin-induced activation of the thioredoxin gene by Nrf2. A differential regulation of the antioxidant responsive element by a switch of its binding factors. J Biol Chem, 276:18399–18406. 2001.
385.
KimY-J, AhnJ-Y, LiangP, IpC, ZhangY, ParkY-M. Human prx1 gene is a target of Nrf2 and is up-regulated by hypoxia/reoxygenation: implication to tumor biology. Cancer Res, 67:546–554. 2007.
386.
KimY-J, LeeW-S, IpC, ChaeH-Z, ParkE-M, ParkY-M. Prx1 suppresses radiation-induced c-Jun NH2-terminal kinase signaling in lung cancer cells through interaction with the glutathione S-transferase Pi/c-Jun NH2-terminal kinase complex. Cancer Res, 66:7136–7142. 2006.
387.
KimYS, LeeHL, LeeKB, ParkJH, ChungWY, LeeKS, SheenSS, ParkKJ, HwangSC. Nuclear factor E2-related factor 2 dependent overexpression of sulfiredoxin and peroxiredoxin III in human lung cancer. Korean J Intern Med, 26:304–313. 2011.
KinnulaVL, LehtonenS, Kaarteenaho-WiikR, LakariE, PääkköP, KangSW, RheeSG, SoiniY. Cell specific expression of peroxiredoxins in human lung and pulmonary sarcoidosis. Thorax, 57:157–164. 2002.
390.
KinoshitaT, HoshinoT, ImaokaH, IchikiH, OkamotoM, KawayamaT, YodoiJ, KatoS, AizawaH. Thioredoxin prevents the development and progression of elastase-induced emphysema. Biochem Biophys Res Commun, 354:712–719. 2007.
391.
KirbyJ, HalliganE, BaptistaMJ, AllenS, HeathPR, HoldenH, BarberSC, LoynesCA, Wood-AllumCA, LunecJ, ShawPJ. Mutant SOD1 alters the motor neuronal transcriptome: implications for familial ALS. Brain, 128:1686–1706. 2005.
392.
KishimotoC, ShiojiK, NakamuraH, NakayamaY, YodoiJ, SasayamaS. Serum thioredoxin (TRX) levels in patients with heart failure. Jpn Circ J, 65:491–494. 2001.
393.
KisuckaJ, ChauhanAK, PattenIS, YesilaltayA, NeumannC, Van EttenRA, KriegerM, WagnerDD. Peroxiredoxin1 prevents excessive endothelial activation and early atherosclerosis. Circ Res, 103:598–605. 2008.
394.
KleemannR, KapurniotuA, FrankRW, GessnerA, MischkeR, FliegerO, JüttnerS, BrunnerH, BernhagenJ. Disulfide analysis reveals a role for macrophage migration inhibitory factor (MIF) as thiol-protein oxidoreductase. J Mol Biol, 280:85–102. 1998.
395.
KnowltonKU, BadorffC. The immune system in viral myocarditis: maintaining the balance. Circ Res, 85:559–561. 1999.
396.
KobayashiM, NakamuraH, YodoiJ, ShiotaK. Immunohistochemical localization of thioredoxin and glutaredoxin in mouse embryos and fetuses. Antioxid Redox Signal, 2:653–663. 2000.
KoenenTB, StienstraR, Van TitsLJ, De GraafJ, StalenhoefAFH, JoostenLAB, TackCJ, NeteaMG. Hyperglycemia activates caspase-1 and TXNIP-mediated IL-1beta transcription in human adipose tissue. Diabetes, 60:517–524. 2011.
399.
KohP-O. Proteomic analysis of focal cerebral ischemic injury in male rats. J Vet Med Sci, 72:181–185. 2010.
400.
KoneruS, PenumathsaSV, ThirunavukkarasuM, ZhanL, MaulikN. Thioredoxin-1 gene delivery induces heme oxygenase-1 mediated myocardial preservation after chronic infarction in hypertensive rats. Am J Hypertens, 22:183–190. 2009.
401.
KongL, ZhouX, LiF, YodoiJ, McGinnisJ, CaoW. Neuroprotective effect of overexpression of thioredoxin on photoreceptor degeneration in Tubby mice. Neurobiol Dis, 38:446–455. 2010.
402.
KorenyM, SterzF, UrayT, SchreiberW, HolzerM, LaggnerA, HerknerH. Effect of cooling after human cardiac arrest on myocardial infarct size. Resuscitation, 80:56–60. 2009.
403.
KosowerNS, KosowerEM. The glutathione status of cells. Int Rev Cytol, 54:109–160. 1978.
404.
KozlovAV, SzalayL, UmarF, KropikK, StaniekK, NiedermüllerH, BahramiS, NohlH. Skeletal muscles, heart, and lung are the main sources of oxygen radicals in old rats. Biochim Biophys Acta, 1740:382–389. 2005.
405.
KozlovG, MäättänenP, ThomasDY, GehringK. A structural overview of the PDI family of proteins. FEBS J, 277:3924–3936. 2010.
406.
KrapfenbauerK, EngidaworkE, CairnsN, FountoulakisM, LubecG. Aberrant expression of peroxiredoxin subtypes in neurodegenerative disorders. Brain Res, 967:152–160. 2003.
407.
Krauth-SiegelRL, CominiMA. Redox control in trypanosomatids, parasitic protozoa with trypanothione-based thiol metabolism. Biochim Biophys Acta, 1780:1236–1248. 2008.
408.
KrimskyI, RackerE. Glutathione, a prosthetic group of glyceraldehyde-3-phosphate dehydrogenase. J Biol Chem, 198:721–729. 1952.
409.
KronschlägerM, GalichaninK, EkströmJ, LouMF, SöderbergPG. Protective effect of the thioltransferase gene on in vivo UVR-300 nm-induced cataract. Invest Ophthalmol Vis Sci, 53:248–252. 2012.
410.
KuboE, FatmaN, AkagiY, BeierDR, SinghSP, SinghDP. TAT-mediated PRDX6 protein transduction protects against eye lens epithelial cell death and delays lens opacity. Am J Physiol Cell Physiol, 294:C842–C855. 2008.
411.
KuboE, HasanovaN, TanakaY, FatmaN, TakamuraY, SinghDP, AkagiY. Protein expression profiling of lens epithelial cells from Prdx6-depleted mice and their vulnerability to UV radiation exposure. Am J Physiol Cell Physiol, 298:C342–C354. 2010.
412.
KuliszA, ChenN, ChandelNS, ShaoZ, SchumackerPT. Mitochondrial ROS initiate phosphorylation of p38 MAP kinase during hypoxia in cardiomyocytes. Am J Physiol Lung Cell Mol Physiol, 282:L1324–L1329. 2002.
LambethJD. NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol, 4:181–189. 2004.
415.
LapointeJ, HekimiS. When a theory of aging ages badly. Cell Mol Life Sci, 67:1–8. 2010.
416.
LappalainenZ, LappalainenJ, OksalaNKJ, LaaksonenDE, KhannaS, SenCK, AtalayM. Diabetes impairs exercise training-associated thioredoxin response and glutathione status in rat brain. J Appl Physiol, 106:461–467. 2009.
417.
LappalainenZ, LappalainenJ, OksalaNKJ, LaaksonenDE, KhannaS, SenCK, AtalayM. Diabetes impairs exercise training-associated thioredoxin response and glutathione status in rat brain. J Appl Physiol, 106:461–467. 2009.
418.
LaurentTC, MooreEC, ReichardP. Enzymatic synthesis of deoxyribonucleotides. iv. isolation and characterization of thioredoxin, the hydrogen donor from Escherichia coli B. J Biol Chem, 239:3436–3444. 1964.
419.
LeeDW, KaurD, ChintaSJ, RajagopalanS, AndersenJK. A disruption in iron-sulfur center biogenesis via inhibition of mitochondrial dithiol glutaredoxin 2 may contribute to mitochondrial and cellular iron dysregulation in mammalian glutathione-depleted dopaminergic cells: implications for Parkinson's disease. Antioxid Redox Signal, 11:2083–2094. 2009.
420.
LeeJ-H, KimK, ParkE-H, AhnK, LimC-J. Expression, characterization and regulation of a Saccharomyces cerevisiae monothiol glutaredoxin (Grx6) gene in Schizosaccharomyces pombe. Mol Cells, 24:316–322. 2007.
421.
LeeSH, KimWS, LeeSH, OhJW, LeeHM, JungHH, JangJW, JunYJ, ChoWJ, JhunHS. Expression and distribution of thioredoxin and thioredoxin reductase in human nasal mucosa and nasal polyp. Acta Otolaryngol, 125:877–882. 2005.
422.
LeeT-H, KimS-U, YuS-L, KimSH, ParkDS, MoonH-B, DhoSH, KwonK-S, KwonHJ, HanY-H, JeongS, KangSW, ShinH-S, LeeK-K, RheeSG, YuD-Y. Peroxiredoxin II is essential for sustaining life span of erythrocytes in mice. Blood, 101:5033–5038. 2003.
423.
LeeYM, ParkSH, ShinD-I, HwangJ-Y, ParkB, ParkY-J, LeeTH, ChaeHZ, JinBK, OhTH, OhYJ. Oxidative modification of peroxiredoxin is associated with drug-induced apoptotic signaling in experimental models of Parkinson disease. J Biol Chem, 283:9986–9998. 2008.
424.
LehtonenST, OhlmeierS, Kaarteenaho-WiikR, HarjuT, PääkköP, SoiniY, KinnulaVL. Does the oxidative stress in chronic obstructive pulmonary disease cause thioredoxin/peroxiredoxin oxidation?Antioxid Redox Signal, 10:813–819. 2008.
425.
LeiX, ChengW. New roles of glutathione peroxidase 1 in oxidative stress and diabetes. Selenium—Its Molecular Biology and Role in Human Health. HatfieldDL, BerryMJ, GladyshevVN. Heidelberg, Germany: Springer, 2006; 173–182.
426.
LekliI, MukherjeeS, RayD, GurusamyN, KimYH, TosakiA, EngelmanRM, HoY-S, DasDK. Functional recovery of diabetic mouse hearts by glutaredoxin-1 gene therapy: role of Akt-FoxO-signaling network. Gene Ther, 17:478–485. 2010.
427.
LenazG, BovinaC, D'AurelioM, FatoR, FormigginiG, GenovaML, GiulianoG, Merlo PichM, PaolucciU, Parenti CastelliG, VenturaB. Role of mitochondria in oxidative stress and aging. Ann N Y Acad Sci, 959:199–213. 2002.
LilligCH, BerndtC, VergnolleO, LönnME, HudemannC, BillE, HolmgrenA. Characterization of human glutaredoxin 2 as iron-sulfur protein: a possible role as redox sensor. Proc Natl Acad Sci U S A, 102:8168–8173. 2005.
434.
LilligCH, HolmgrenA. Thioredoxin and related molecules—from biology to health and disease. Antioxid Redox Signal, 9:25–47. 2007.
435.
LilligCH, LönnME, EnokssonM, FernandesAP, HolmgrenA. Short interfering RNA-mediated silencing of glutaredoxin 2 increases the sensitivity of HeLa cells toward doxorubicin and phenylarsine oxide. Proc Natl Acad Sci U S A, 101:13227–13232. 2004.
436.
LillR, KispalG. Maturation of cellular Fe-S proteins: an essential function of mitochondria. Trends Biochem Sci, 25:352–356. 2000.
437.
LillR, MühlenhoffU. Iron-sulfur protein biogenesis in eukaryotes: components and mechanisms. Annu Rev Cell Dev Biol, 22:457–486. 2006.
438.
LiL, ShojiW, TakanoH, NishimuraN, AokiY, TakahashiR, GotoS, KaifuT, TakaiT, ObinataM. Increased susceptibility of MER5 (peroxiredoxin III) knockout mice to LPS-induced oxidative stress. Biochem Biophys Res Commun, 355:715–721. 2007.
439.
LimJ, LudererU. Oxidative damage increases and antioxidant gene expression decreases with aging in the mouse ovary. Biol Reprod, 84:775–782. 2011.
440.
LiN, OberleyTD. Modulation of antioxidant enzymes, reactive oxygen species, and glutathione levels in manganese superoxide dismutase-overexpressing NIH/3T3 fibroblasts during the cell cycle. J Cell Physiol, 177:148–160. 1998.
441.
LippoldtA, PadillaCA, GerstH, AndbjerB, RichterE, HolmgrenA, FuxeK. Localization of thioredoxin in the rat brain and functional implications. J Neurosci, 15:6747–6756. 1995.
442.
LiuW, NakamuraH, ShiojiK, TanitoM, OkaS, AhsanMK, SonA, IshiiY, KishimotoC, YodoiJ. Thioredoxin-1 ameliorates myosin-induced autoimmune myocarditis by suppressing chemokine expressions and leukocyte chemotaxis in mice. Circulation, 110:1276–1283. 2004.
443.
LiuY, MinW. Thioredoxin promotes ASK1 ubiquitination and degradation to inhibit ASK1-mediated apoptosis in a redox activity-independent manner. Circ Res, 90:1259–1266. 2002.
444.
LiX, TangK, XieB, LiS, RozanskiGJ. Regulation of Kv4 channel expression in failing rat heart by the thioredoxin system. Am J Physiol Heart Circ Physiol, 295:H416–H424. 2008.
445.
LöfgrenS, FernandoMR, XingK-Y, WangY, KuszynskiCA, HoY-S, LouMF. Effect of thioltransferase (glutaredoxin) deletion on cellular sensitivity to oxidative stress and cell proliferation in lens epithelial cells of thioltransferase knockout mouse. Invest Ophthalmol Vis Sci, 49:4497–4505. 2008.
446.
LongoVD, GrallaEB, ValentineJS. Superoxide dismutase activity is essential for stationary phase survival in Saccharomyces cerevisiae. Mitochondrial production of toxic oxygen species in vivo. J Biol Chem, 271:12275–12280. 1996.
447.
LönnME, HudemannC, BerndtC, CherkasovV, CapaniF, HolmgrenA, LilligCH. Expression pattern of human glutaredoxin 2 isoforms: identification and characterization of two testis/cancer cell-specific isoforms. Antioxid Redox Signal, 10:547–557. 2008.
448.
Lopes de FariaJB, SilvaKC, Lopes de FariaJM. The contribution of hypertension to diabetic nephropathy and retinopathy: the role of inflammation and oxidative stress. Hypertens Res, 34:413–422. 2011.
449.
LoschenG, FlohéL, ChanceB. Respiratory chain linked H(2)O(2) production in pigeon heart mitochondria. FEBS Lett, 18:261–264. 1971.
LüdemannH, DormeyerM, SticherlingC, StallmannD, FollmannH, Krauth-SiegelRL. Trypanosoma brucei tryparedoxin, a thioredoxin-like protein in African trypanosomes. FEBS Lett, 431:381–385. 1998.
452.
LuJ, BerndtC, HolmgrenA. Metabolism of selenium compounds catalyzed by the mammalian selenoprotein thioredoxin reductase. Biochim Biophys Acta, 1790:1513–1519. 2009.
453.
LundbergM, FernandesAP, KumarS, HolmgrenA. Cellular and plasma levels of human glutaredoxin 1 and 2 detected by sensitive ELISA systems. Biochem Biophys Res Commun, 319:801–809. 2004.
454.
LundströmJ, HolmgrenA. Protein disulfide-isomerase is a substrate for thioredoxin reductase and has thioredoxin-like activity. J Biol Chem, 265:9114–9120. 1990.
455.
LuthmanM, ErikssonS, HolmgrenA, ThelanderL. Glutathione-dependent hydrogen donor system for calf thymus ribonucleoside-diphosphate reductase. Proc Natl Acad Sci U S A, 76:2158–2162. 1979.
456.
LuthmanM, HolmgrenA. Glutaredoxin from calf thymus. Purification to homogeneity. J Biol Chem, 257:6686–6690. 1982.
457.
LysellJ, Stjernholm VladicY, CiarloN, HolmgrenA, SahlinL. Immunohistochemical determination of thioredoxin and glutaredoxin distribution in the human cervix, and possible relation to cervical ripening. Gynecol Endocrinol, 17:303–310. 2003.
458.
MadianAG, MyracleAD, Diaz-MaldonadoN, RochelleNS, JanleEM, RegnierFE. Differential carbonylation of proteins as a function of in vivo oxidative stress. J Proteome Res, 10:3959–3972. 2011.
459.
MaD, WarabiE, YanagawaT, KimuraS, HaradaH, YamagataK, IshiiT. Peroxiredoxin I plays a protective role against cisplatin cytotoxicity through mitogen activated kinase signals. Oral Oncol, 45:1037–1043. 2009.
460.
MagakiS, RaghavanR, MuellerC, ObergKC, VintersHV, KirschWM. Iron, copper, and iron regulatory protein 2 in Alzheimer's disease and related dementias. Neurosci Lett, 418:72–76. 2007.
461.
MagnussonCG, BjörnstedtM, HolmgrenA. Human IgG is substrate for the thioredoxin system: differential cleavage pattern of interchain disulfide bridges in IgG subclasses. Mol Immunol, 34:709–717. 1997.
462.
MalaspinaA, KaushikN, De BellerocheJ. Differential expression of 14 genes in amyotrophic lateral sclerosis spinal cord detected using gridded cDNA arrays. J Neurochem, 77:132–145. 2001.
463.
MalikG, GorbounovN, DasS, GurusamyN, OtaniH, MaulikN, GoswamiS, DasDK. Ischemic preconditioning triggers nuclear translocation of thioredoxin and its interaction with Ref-1 potentiating a survival signal through the PI-3-kinase-Akt pathway. Antioxid Redox Signal, 8:2101–2109. 2006.
464.
MalikG, NagyN, HoY-S, MaulikN, DasDK. Role of glutaredoxin-1 in cardioprotection: an insight with Glrx1 transgenic and knockout animals. J Mol Cell Cardiol, 44:261–269. 2008.
465.
MannickJB. Regulation of apoptosis by protein S-nitrosylation. Amino Acids, 32:523–526. 2007.
466.
MansfieldKD, GuzyRD, PanY, YoungRM, CashTP, SchumackerPT, SimonMC. Mitochondrial dysfunction resulting from loss of cytochrome c impairs cellular oxygen sensing and hypoxic HIF-alpha activation. Cell Metab, 1:393–399. 2005.
467.
MarinoSM, GladyshevVN. Structural analysis of cysteine S-nitrosylation: a modified acid-based motif and the emerging role of trans-nitrosylation. J Mol Biol, 395:844–859. 2010.
468.
MarkovicJ, García-GimenezJL, GimenoA, ViñaJ, PallardóFV. Role of glutathione in cell nucleus. Free Radic Res, 44:721–733. 2010.
469.
MarquezVE, AriasDG, PiattoniCV, RobelloC, IglesiasAA, GuerreroSA. Cloning, expression, and characterization of a dithiol glutaredoxin from Trypanosoma cruzi. Antioxid Redox Signal, 12:787–792. 2010.
470.
Martinez-VicenteM, SovakG, CuervoAM. Protein degradation and aging. Exp Gerontol, 40:622–633. 2005.
471.
MartinJL. Thioredoxin—a fold for all reasons. Structure, 3:245–250. 1995.
472.
MasoroEJ. Caloric restriction and aging: an update. Exp Gerontol, 35:299–305. 2000.
473.
MatsueH, EdelbaumD, ShalhevetD, MizumotoN, YangC, MummertME, OedaJ, MasayasuH, TakashimaA. Generation and function of reactive oxygen species in dendritic cells during antigen presentation. J Immunol, 171:3010–3018. 2003.
474.
MatsuiM, OshimaM, OshimaH, TakakuK, MaruyamaT, YodoiJ, TaketoMM. Early embryonic lethality caused by targeted disruption of the mouse thioredoxin gene. Dev Biol, 178:179–815. 1996.
475.
MatsuokaT, KajimotoY, WatadaH, KanetoH, KishimotoM, UmayaharaY, FujitaniY, KamadaT, KawamoriR, YamasakiY. Glycation-dependent, reactive oxygen species-mediated suppression of the insulin gene promoter activity in HIT cells. J Clin Invest, 99:144–150. 1997.
476.
MatsushimaS, IdeT, YamatoM, MatsusakaH, HattoriF, IkeuchiM, KubotaT, SunagawaK, HasegawaY, KuriharaT, OikawaS, KinugawaS, TsutsuiH. Overexpression of mitochondrial peroxiredoxin-3 prevents left ventricular remodeling and failure after myocardial infarction in mice. Circulation, 113:1779–1786. 2006.
477.
MatsushimaS, ZablockiD, SadoshimaJ. Application of recombinant thioredoxin1 for treatment of heart disease. J Mol Cell Cardiol, 51:570–573. 2011.
478.
MatsushimaY, NanriH, NaraS, OkufujiT, OhtaM, HachisukaK, IkedaM. Hindlimb unloading decreases thioredoxin-related antioxidant proteins and increases thioredoxin-binding protein-2 in rat skeletal muscle. Free Radic Res, 40:715–722. 2006.
479.
MatsuzawaA, IchijoH. Redox control of cell fate by MAP kinase: physiological roles of ASK1-MAP kinase pathway in stress signaling. Biochim Biophys Acta, 1780:1325–1336. 2008.
480.
MatthewsJR, WakasugiN, VirelizierJL, YodoiJ, HayRT. Thioredoxin regulates the DNA binding activity of NF-kappa B by reduction of a disulphide bond involving cysteine 62. Nucleic Acids Res, 20:3821–3830. 1992.
481.
MauriceMM, NakamuraH, GringhuisS, OkamotoT, YoshidaS, KullmannF, LechnerS, Van der VoortEA, LeowA, VersendaalJ, Muller-LadnerU, YodoiJ, TakPP, BreedveldFC, VerweijCL. Expression of the thioredoxin-thioredoxin reductase system in the inflamed joints of patients with rheumatoid arthritis. Arthritis Rheum, 42:2430–2439. 1999.
482.
MayJM, MendirattaS, HillKE, BurkRF. Reduction of dehydroascorbate to ascorbate by the selenoenzyme thioredoxin reductase. J Biol Chem, 272:22607–22610. 1997.
483.
MaZA, ZhaoZ, TurkJ. Mitochondrial dysfunction and β-cell failure in type 2 diabetes mellitus. Exp Diabetes Res, 2012:703538. 2012.
484.
McCordJM, FridovichI. The utility of superoxide dismutase in studying free radical reactions. I. Radicals generated by the interaction of sulfite, dimethyl sulfoxide, and oxygen. J Biol Chem, 244:6056–6063. 1969.
485.
McCordJM, FridovichI. The utility of superoxide dismutase in studying free radical reactions. II. The mechanism of the mediation of cytochrome c reduction by a variety of electron carriers. J Biol Chem, 245:1374–1377. 1970.
486.
McDonaghB, PadillaCA, PedrajasJR, BárcenaJA. Biosynthetic and iron metabolism is regulated by thiol proteome changes dependent on glutaredoxin-2 and mitochondrial peroxiredoxin-1 in Saccharomyces cerevisiae. J Biol Chem, 286:15565–15576. 2011.
487.
McIntyreLA, FergussonDA, HébertPC, MoherD, HutchisonJS. Prolonged therapeutic hypothermia after traumatic brain injury in adults: a systematic review. JAMA, 289:2992–2999. 2003.
488.
MeisterA. Biosynthesis and functions of glutathione, an essential biofactor. J Nutr Sci Vitaminol Spec, No:1–6. 1992.
489.
MeisterA, AndersonME. Glutathione. Annu Rev Biochem, 52:711–760. 1983.
490.
MeseckeN, MittlerS, EckersE, HerrmannJM, DeponteM. Two novel monothiol glutaredoxins from Saccharomyces cerevisiae provide further insight into iron-sulfur cluster binding, oligomerization, and enzymatic activity of glutaredoxins. Biochemistry, 47:1452–1463. 2008.
491.
MessinaJP, LawrenceDA. Cell cycle progression of glutathione-depleted human peripheral blood mononuclear cells is inhibited at S phase. J Immunol, 143:1974–1981. 1989.
492.
MetzenE, ZhouJ, JelkmannW, FandreyJ, BrüneB. Nitric oxide impairs normoxic degradation of HIF-1alpha by inhibition of prolyl hydroxylases. Mol Biol Cell, 14:3470–3481. 2003.
493.
MeyerLM, LöfgrenS, HoY-S, LouM, WegenerA, HolzF, SöderbergP. Absence of glutaredoxin1 increases lens susceptibility to oxidative stress induced by UVR-B. Exp Eye Res, 89:833–839. 2009.
494.
MeyerM, PahlHL, BaeuerlePA. Regulation of the transcription factors NF-kappa B and AP-1 by redox changes. Chem Biol Interact, 91:91–100. 1994.
495.
MieyalJJ, GalloglyMM, QanungoS, SabensEA, SheltonMD. Molecular mechanisms and clinical implications of reversible protein S-glutathionylation. Antioxid Redox Signal, 10:1941–1988. 2008.
496.
MillerJAJr., MillerFS, WestinB. Hypothermia in the treatment of asphyxia neonatorum. Biol Neonat, 6:148–163. 1964.
497.
Miranda-VizueteA, GustafssonJA, SpyrouG. Molecular cloning and expression of a cDNA encoding a human thioredoxin-like protein. Biochem Biophys Res Commun, 243:284–288. 1998.
498.
Miranda-VizueteA, LjungJ, DamdimopoulosAE, GustafssonJA, OkoR, Pelto-HuikkoM, SpyrouG. Characterization of Sptrx, a novel member of the thioredoxin family specifically expressed in human spermatozoa. J Biol Chem, 276:31567–31574. 2001.
499.
MisetaA, CsutoraP. Relationship between the occurrence of cysteine in proteins and the complexity of organisms. Mol Biol Evol, 17:1232–1239. 2000.
500.
MisraMK, SarwatM, BhakuniP, TutejaR, TutejaN. Oxidative stress and ischemic myocardial syndromes. Med Sci Monit, 15:RA209–RA219. 2009.
501.
MisséD, YsselH, TrabattoniD, ObletC, Lo CaputoS, MazzottaF, PèneJ, GonzalezJ-P, ClericiM, VeasF. IL-22 participates in an innate anti-HIV-1 host-resistance network through acute-phase protein induction. J Immunol, 178:407–415. 2007.
502.
MitchellDA, MarlettaMA. Thioredoxin catalyzes the S-nitrosation of the caspase-3 active site cysteine. Nat Chem Biol, 1:154–158. 2005.
MitsuiA, HamuroJ, NakamuraH, KondoN, HirabayashiY, Ishizaki-KoizumiS, HirakawaT, InoueT, YodoiJ. Overexpression of human thioredoxin in transgenic mice controls oxidative stress and life span. Antioxid Redox Signal, 4:693–696. 2002.
505.
MiyamotoM, KishimotoC, ShiojiK, NakamuraH, ToyokuniS, NakayamaY, KitaM, YodoiJ, SasayamaS. Difference in thioredoxin expression in viral myocarditis in inbred strains of mice. Jpn Circ J, 65:561–564. 2001.
506.
MiyamotoN, IzumiH, MiyamotoR, KubotaT, TawaraA, SasaguriY, KohnoK. Nipradilol and timolol induce Foxo3a and peroxiredoxin 2 expression and protect trabecular meshwork cells from oxidative stress. Invest Ophthalmol Vis Sci, 50:2777–2784. 2009.
507.
MiyamotoS, KawanoH, HokamakiJ, SoejimaH, KojimaS, KudohT, NagayoshiY, SugiyamaS, SakamotoT, YoshimuraM, NakamuraH, YodoiJ, OgawaH. Increased plasma levels of thioredoxin in patients with glucose intolerance. Intern Med, 44:1127–1132. 2005.
508.
MizusawaH, IshiiT, BannaiS. Peroxiredoxin I (macrophage 23 kDa stress protein) is highly and widely expressed in the rat nervous system. Neurosci Lett, 283:57–60. 2000.
509.
MochizukiM, KwonY-W, YodoiJ, MasutaniH. Thioredoxin regulates cell cycle via the ERK1/2-cyclin D1 pathway. Antioxid Redox Signal, 11:2957–2971. 2009.
510.
MoghaddamDA, HeberA, CapinD, KreutzT, OpitzD, LenzenE, BlochW, BrixiusK, BrinkmannC. Training increases peroxiredoxin 2 contents in the erythrocytes of overweight/obese men suffering from type 2 diabetes. Wien Med Wochenschr, 161:511–518. 2011.
511.
MolitorisBA, MarrsJ. The role of cell adhesion molecules in ischemic acute renal failure. Am J Med, 106:583–592. 1999.
512.
MoonE-Y, KangJS, HanSH, YangK-H, PyoS, LeeM-Y, LeeH-K, YuD-Y. Differential role of peroxiredoxin II (PrxII) on the expression of toll-like receptor 4 (TLR4) and B-cell activating factor (BAFF) in ovalbumin (OVA)-induced mouse asthma. Int Immunopharmacol, 8:935–944. 2008.
513.
MoosPJ, EdesK, CassidyP, MassudaE, FitzpatrickFA. Electrophilic prostaglandins and lipid aldehydes repress redox-sensitive transcription factors p53 and hypoxia-inducible factor by impairing the selenoprotein thioredoxin reductase. J Biol Chem, 278:745–750. 2003.
MorenoSG, LauxG, BrielmeierM, BornkammGW, ConradM. Testis-specific expression of the nuclear form of phospholipid hydroperoxide glutathione peroxidase (PHGPx)Biol Chem, 384:635–643. 2003.
516.
MorihiraM, HasebeN, BaljinnyamE, SumitomoK, MatsusakaT, IzawaK, FujinoT, FukuzawaJ, KikuchiK. Ischemic preconditioning enhances scavenging activity of reactive oxygen species and diminishes transmural difference of infarct size. Am J Physiol Heart Circ Physiol, 290:H577–H583. 2006.
517.
MorinakaA, FunatoY, UesugiK, MikiH. Oligomeric peroxiredoxin-I is an essential intermediate for p53 to activate MST1 kinase and apoptosis. Oncogene, 30:4208–4218. 2011.
518.
MorrisonSJ, CseteM, GrovesAK, MelegaW, WoldB, AndersonDJ. Culture in reduced levels of oxygen promotes clonogenic sympathoadrenal differentiation by isolated neural crest stem cells. J Neurosci, 20:7370–7376. 2000.
519.
MoskovitzJ. Roles of methionine suldfoxide reductases in antioxidant defense, protein regulation and survival. Curr Pharm Des, 11:1451–1457. 2005.
520.
MoskovitzJ. Methionine sulfoxide reductases: ubiquitous enzymes involved in antioxidant defense, protein regulation, and prevention of aging-associated diseases. Biochim Biophys Acta, 1703:213–219. 2005.
521.
MühlenhoffU, GerberJ, RichhardtN, LillR. Components involved in assembly and dislocation of iron-sulfur clusters on the scaffold protein Isu1p. EMBO J, 22:4815–4825. 2003.
522.
MühlenhoffU, MolikS, GodoyJR, UzarskaMA, RichterN, SeubertA, ZhangY, StubbeJ, PierrelF, HerreroE, LilligCH, LillR. Cytosolic monothiol glutaredoxins function in intracellular iron sensing and trafficking via their bound iron-sulfur cluster. Cell Metab, 12:373–385. 2010.
523.
MukherjeeA, MartinSG. The thioredoxin system: a key target in tumour and endothelial cells. Br J Radiol, 81:S57–S68. 2008.
524.
MüllerBAL, DhallaNS. Mechanisms of the beneficial actions of ischemic preconditioning on subcellular remodeling in ischemic-reperfused heart. Curr Cardiol Rev, 6:255–264. 2010.
525.
MulthaupG, RuppertT, SchlicksuppA, HesseL, BeherD, MastersCL, BeyreutherK. Reactive oxygen species and Alzheimer's disease. Biochem Pharmacol, 54:533–539. 1997.
526.
MunemasaY, AhnJH, KwongJMK, CaprioliJ, PiriN. Redox proteins thioredoxin 1 and thioredoxin 2 support retinal ganglion cell survival in experimental glaucoma. Gene Ther, 16:17–25. 2009.
527.
MunemasaY, KitaokaY, KuribayashiJ, UenoS. Modulation of mitochondria in the axon and soma of retinal ganglion cells in a rat glaucoma model. J Neurochem, 115:1508–1519. 2010.
528.
MunemasaY, KwongJMK, KimSH, AhnJH, CaprioliJ, PiriN. Thioredoxins 1 and 2 protect retinal ganglion cells from pharmacologically induced oxidative stress, optic nerve transection and ocular hypertension. Adv Exp Med Biol, 664:355–363. 2010.
529.
MurataH, IharaY, NakamuraH, YodoiJ, SumikawaK, KondoT. Glutaredoxin exerts an antiapoptotic effect by regulating the redox state of Akt. J Biol Chem, 278:50226–50233. 2003.
530.
MurryCE, JenningsRB, ReimerKA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation, 74:1124–1136. 1986.
531.
MuZM, YinXY, ProchownikEV. Pag, a putative tumor suppressor, interacts with the Myc Box II domain of c-Myc and selectively alters its biological function and target gene expression. J Biol Chem, 277:43175–43184. 2002.
532.
NadeemA, ChhabraSK, MasoodA, RajHG. Increased oxidative stress and altered levels of antioxidants in asthma. J Allergy Clin Immunol, 111:72–78. 2003.
533.
NagaokaY, IuchiY, IkedaY, FujiiJ. Glutathione reductase is expressed at high levels in pancreatic islet cells. Redox Rep, 9:321–324. 2004.
534.
NagyN, MalikG, FisherAB, DasDK. Targeted disruption of peroxiredoxin 6 gene renders the heart vulnerable to ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol, 291:H2636–H2640. 2006.
535.
NagyN, MalikG, TosakiA, HoY-S, MaulikN, DasDK. Overexpression of glutaredoxin-2 reduces myocardial cell death by preventing both apoptosis and necrosis. J Mol Cell Cardiol, 44:252–260. 2008.
536.
NaidooN. ER and aging-Protein folding and the ER stress response. Ageing Res Rev, 8:150–159. 2009.
537.
NakamuraH. Extracellular functions of thioredoxin. Novartis Found Symp, 291:184–192discussion 192–195, 221–2242008.
538.
NakamuraH, HerzenbergLA, BaiJ, ArayaS, KondoN, NishinakaY, HerzenbergLA, YodoiJ. Circulating thioredoxin suppresses lipopolysaccharide-induced neutrophil chemotaxis. Proc Natl Acad Sci U S A, 98:15143–15148. 2001.
539.
NakamuraH, HoshinoY, OkuyamaH, MatsuoY, YodoiJ. Thioredoxin 1 delivery as new therapeutics. Adv Drug Deliv Rev, 61:303–309. 2009.
540.
NakamuraH, MasutaniH, TagayaY, YamauchiA, InamotoT, NanbuY, FujiiS, OzawaK, YodoiJ. Expression and growth-promoting effect of adult T-cell leukemia-derived factor. A human thioredoxin homologue in hepatocellular carcinoma. Cancer, 69:2091–2097. 1992.
541.
NakamuraH, MasutaniH, YodoiJ. Extracellular thioredoxin and thioredoxin-binding protein 2 in control of cancer. Semin Cancer Biol, 16:444–451. 2006.
542.
NakamuraH, De RosaSC, YodoiJ, HolmgrenA, GhezziP, HerzenbergLA, HerzenbergLA. Chronic elevation of plasma thioredoxin: inhibition of chemotaxis and curtailment of life expectancy in AIDS. Proc Natl Acad Sci U S A, 98:2688–2693. 2001.
543.
NakamuraH, De RosaS, RoedererM, AndersonMT, DubsJG, YodoiJ, HolmgrenA, HerzenbergLA, HerzenbergLA. Elevation of plasma thioredoxin levels in HIV-infected individuals. Int Immunol, 8:603–611. 1996.
544.
NeumannCA, FangQ. Are peroxiredoxins tumor suppressors?Curr Opin Pharmacol, 7:375–380. 2007.
545.
NeumannCA, KrauseDS, CarmanCV, DasS, DubeyDP, AbrahamJL, BronsonRT, FujiwaraY, OrkinSH, Van EttenRA. Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression. Nature, 424:561–565. 2003.
546.
NimataM, KishimotoC, ShiojiK, IshizakiK, KitaguchiS, HashimotoT, NagataN, KawaiC. Upregulation of redox-regulating protein, thioredoxin, in endomyocardial biopsy samples of patients with myocarditis and cardiomyopathies. Mol Cell Biochem, 248:193–196. 2003.
547.
NishinoT, OkamotoK, EgerBT, PaiEF, NishinoT. Mammalian xanthine oxidoreductase—mechanism of transition from xanthine dehydrogenase to xanthine oxidase. FEBS J, 275:3278–3289. 2008.
548.
NishiyamaA, MatsuiM, IwataS, HirotaK, MasutaniH, NakamuraH, TakagiY, SonoH, GonY, YodoiJ. Identification of thioredoxin-binding protein-2/vitamin D(3) up-regulated protein 1 as a negative regulator of thioredoxin function and expression. J Biol Chem, 274:21645–21650. 1999.
549.
NoblancA, KocerA, ChaboryE, VernetP, SaezF, CadetR, ConradM, DrevetJR. Glutathione peroxidases at work on epididymal spermatozoa: an example of the dual effect of reactive oxygen species on mammalian male fertilizing ability. J Androl, 32:641–650. 2011.
550.
NogocekeE, GommelDU, KiessM, KaliszHM, FlohéL. A unique cascade of oxidoreductases catalyses trypanothione-mediated peroxide metabolism in Crithidia fasciculata. Biol Chem, 378:827–836. 1997.
551.
NonnL, BerggrenM, PowisG. Increased expression of mitochondrial peroxiredoxin-3 (thioredoxin peroxidase-2) protects cancer cells against hypoxia and drug-induced hydrogen peroxide-dependent apoptosis. Mol Cancer Res, 1:682–689. 2003.
552.
NonnL, WilliamsRR, EricksonRP, PowisG. The absence of mitochondrial thioredoxin 2 causes massive apoptosis, exencephaly, and early embryonic lethality in homozygous mice. Mol Cell Biol, 23:916–922. 2003.
553.
NonyPA, SchnellmannRG. Mechanisms of renal cell repair and regeneration after acute renal failure. J Pharmacol Exp Ther, 304:905–912. 2003.
554.
NordbergJ, ArnérES. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic Biol Med, 31:1287–1312. 2001.
555.
OblongJE, BerggrenM, GasdaskaPY, PowisG. Site-directed mutagenesis of active site cysteines in human thioredoxin produces competitive inhibitors of human thioredoxin reductase and elimination of mitogenic properties of thioredoxin. J Biol Chem, 269:11714–11720. 1994.
OdehH, HunkerKL, BelyantsevaIA, AzaiezH, AvenariusMR, ZhengL, PetersLM, GagnonLH, HagiwaraN, SkynnerMJ, BrilliantMH, AllenND, RiazuddinS, JohnsonKR, RaphaelY, NajmabadiH, FriedmanTB, BartlesJR, SmithRJH, KohrmanDC. Mutations in Grxcr1 are the basis for inner ear dysfunction in the pirouette mouse. Am J Hum Genet, 86:148–160. 2010.
558.
Okado-MatsumotoA, MatsumotoA, FujiiJ, TaniguchiN. Peroxiredoxin IV is a secretable protein with heparin-binding properties under reduced conditions. J Biochem, 127:493–501. 2000.
559.
OliveiraL, BoutonC, DrapierJC. Thioredoxin activation of iron regulatory proteins. Redox regulation of RNA binding after exposure to nitric oxide. J Biol Chem, 274:516–521. 1999.
560.
Orme-JohnsonWH, BeinertH. On the formation of the superoxide anion radical during the reaction of reduced iron-sulfur proteins with oxygen. Biochem Biophys Res Commun, 36:905–911. 1969.
PaiHV, StarkeDW, LesnefskyEJ, HoppelCL, MieyalJJ. What is the functional significance of the unique location of glutaredoxin 1 (GRx1) in the intermembrane space of mitochondria?Antioxid Redox Signal, 9:2027–2033. 2007.
566.
PakJH, ChoiWH, LeeHM, JooW-D, KimJ-H, KimY-T, KimY-M, NamJ-H. Peroxiredoxin 6 overexpression attenuates cisplatin-induced apoptosis in human ovarian cancer cells. Cancer Invest, 29:21–28. 2011.
PalandeKK, BeekmanR, Van der MeerenLE, BeverlooHB, ValkPJM, TouwIP. The antioxidant protein peroxiredoxin 4 is epigenetically down regulated in acute promyelocytic leukemia. PLoS One, 6:e16340. 2011.
569.
PalmerLA, GastonB, JohnsRA. Normoxic stabilization of hypoxia-inducible factor-1 expression and activity: redox-dependent effect of nitrogen oxides. Mol Pharmacol, 58:1197–1203. 2000.
570.
PandolfoM. Iron and Friedreich ataxia. J Neural Transm Suppl, 70:143–146. 2006.
571.
PanS, BerkBC. Glutathiolation regulates tumor necrosis factor-alpha-induced caspase-3 cleavage and apoptosis: key role for glutaredoxin in the death pathway. Circ Res, 100:213–219. 2007.
572.
PantopoulosK. Iron metabolism and the IRE/IRP regulatory system: an update. Ann N Y Acad Sci, 1012:1–13. 2004.
ParkJW, MieyalJJ, RheeSG, ChockPB. Deglutathionylation of 2-Cys peroxiredoxin is specifically catalyzed by sulfiredoxin. J Biol Chem, 284:23364–23374. 2009.
577.
ParksD, BolingerR, MannK. Redox state regulates binding of p53 to sequence-specific DNA, but not to non-specific or mismatched DNA. Nucleic Acids Res, 25:1289–1295. 1997.
578.
ParkS-Y, YuX, IpC, MohlerJL, BognerPN, ParkY-M. Peroxiredoxin 1 interacts with androgen receptor and enhances its transactivation. Cancer Res, 67:9294–9303. 2007.
PedrajasJR, PadillaCA, McDonaghB, BárcenaJA. Glutaredoxin participates in the reduction of peroxides by the mitochondrial 1-CYS peroxiredoxin in Saccharomyces cerevisiae. Antioxid Redox Signal, 13:249–258. 2010.
584.
PekkariK, Avila-CariñoJ, BengtssonA, GurunathR, ScheyniusA, HolmgrenA. Truncated thioredoxin (Trx80) induces production of interleukin-12 and enhances CD14 expression in human monocytes. Blood, 97:3184–3190. 2001.
585.
PekkariK, GoodarziMT, ScheyniusA, HolmgrenA, Avila-CariñoJ. Truncated thioredoxin (Trx80) induces differentiation of human CD14+ monocytes into a novel cell type (TAMs) via activation of the MAP kinases p38, ERK, and JNK. Blood, 105:1598–1605. 2005.
586.
PekkariK, GurunathR, ArnerES, HolmgrenA. Truncated thioredoxin is a mitogenic cytokine for resting human peripheral blood mononuclear cells and is present in human plasma. J Biol Chem, 275:37474–37480. 2000.
PeltoniemiMJ, RytiläPH, HarjuTH, SoiniYM, SalmenkiviKM, RuddockLW, KinnulaVL. Modulation of glutaredoxin in the lung and sputum of cigarette smokers and chronic obstructive pulmonary disease. Respir Res, 7:133. 2006.
589.
PeltoniemiM, Kaarteenaho-WiikR, SäilyM, SormunenR, PääkköP, HolmgrenA, SoiniY, KinnulaVL. Expression of glutaredoxin is highly cell specific in human lung and is decreased by transforming growth factor-beta in vitro and in interstitial lung diseases in vivo. Hum Pathol, 35:1000–1007. 2004.
590.
PengY, YangP-H, GuoY, NgSSM, LiuJ, FungPCW, TayD, GeJ, HeM-L, KungH-F, LinMC. Catalase and peroxiredoxin 5 protect Xenopus embryos against alcohol-induced ocular anomalies. Invest Ophthalmol Vis Sci, 45:23–29. 2004.
591.
PenningtonJD, JacobsKM, SunL, Bar-SelaG, MishraM, GiusD. Thioredoxin and thioredoxin reductase as redox-sensitive molecular targets for cancer therapy. Curr Pharm Des, 13:3368–3377. 2007.
592.
PennisiG, CorneliusC, CavallaroMM, SalinaroAT, CambriaMT, PennisiM, BellaR, MiloneP, VentimigliaB, MiglioreMR, Di RenzoL, De LorenzoA, CalabreseV. Redox regulation of cellular stress response in multiple sclerosis. Biochem Pharmacol, 82:1490–1499. 2011.
593.
PérezVI, BokovA, Van RemmenH, MeleJ, RanQ, IkenoY, RichardsonA. Is the oxidative stress theory of aging dead?Biochim Biophys Acta, 1790:1005–1014. 2009.
594.
PérezVI, CortezLA, LewCM, RodriguezM, WebbCR, Van RemmenH, ChaudhuriA, QiW, LeeS, BokovA, FokW, JonesD, RichardsonA, YodoiJ, ZhangY, TominagaK, HubbardGB, IkenoY. Thioredoxin 1 overexpression extends mainly the earlier part of life span in mice. J Gerontol A Biol Sci Med Sci, 66:1286–1299. 2011.
595.
PerroneL, DeviTS, HosoyaK-I, TerasakiT, SinghLP. Inhibition of TXNIP expression in vivo blocks early pathologies of diabetic retinopathy. Cell Death Dis, 1:e65. 2010.
596.
PerroneL, DeviTS, HosoyaK, TerasakiT, SinghLP. Thioredoxin interacting protein (TXNIP) induces inflammation through chromatin modification in retinal capillary endothelial cells under diabetic conditions. J Cell Physiol, 221:262–272. 2009.
597.
PerryTL, GodinDV, HansenS. Parkinson's disease: a disorder due to nigral glutathione deficiency?Neurosci Lett, 33:305–310. 1982.
598.
PerryTL, YongVW. Idiopathic Parkinson's disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients. Neurosci Lett, 67:269–274. 1986.
599.
PetersonJD, HerzenbergLA, VasquezK, WaltenbaughC. Glutathione levels in antigen-presenting cells modulate Th1 versus Th2 response patterns. Proc Natl Acad Sci U S A, 95:3071–3076. 1998.
600.
PetropoulosI, FriguetB. Protein maintenance in aging and replicative senescence: a role for the peptide methionine sulfoxide reductases. Biochim Biophys Acta, 1703:261–266. 2005.
601.
PhelanSA, WangX, WallbrandtP, Forsman-SembK, PaigenB. Overexpression of Prdx6 reduces H2O2 but does not prevent diet-induced atherosclerosis in the aortic root. Free Radic Biol Med, 35:1110–1120. 2003.
602.
PhillipsPG, BirnbyLM, NarendranA. Hypoxia induces capillary network formation in cultured bovine pulmonary microvessel endothelial cells. Am J Physiol, 268:L789–L800. 1995.
603.
PicciocchiA, SaguezC, BoussacA, Cassier-ChauvatC, ChauvatF. CGFS-type monothiol glutaredoxins from the cyanobacterium Synechocystis PCC6803 and other evolutionary distant model organisms possess a glutathione-ligated [2Fe-2S] cluster. Biochemistry, 46:15018–15026. 2007.
604.
PierrouS, BrobergP, O'DonnellRA, PawłowskiK, VirtalaR, LindqvistE, RichterA, WilsonSJ, AngcoG, MöllerS, BergstrandH, KoopmannW, WieslanderE, StrömstedtP-E, HolgateST, DaviesDE, LundJ, DjukanovicR. Expression of genes involved in oxidative stress responses in airway epithelial cells of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 175:577–586. 2007.
605.
Pineda-MolinaE, KlattP, VázquezJ, MarinaA, García de LacobaM, Pérez-SalaD, LamasS. Glutathionylation of the p50 subunit of NF-kappaB: a mechanism for redox-induced inhibition of DNA binding. Biochemistry, 40:14134–14142. 2001.
606.
PooleLB. Formation and functions of protein sulfenic acids. Curr Protoc Toxicol Chapter, 17:Unit17.1. 2004.
607.
PotterLR. Guanylyl cyclase structure, function and regulation. Cell Signal, 23:1921–1926. 2011.
608.
PowerJHT, AsadS, ChatawayTK, CheginiF, ManavisJ, TemlettJA, JensenPH, BlumbergsPC, GaiW-P. Peroxiredoxin 6 in human brain: molecular forms, cellular distribution and association with Alzheimer's disease pathology. Acta Neuropathol, 115:611–622. 2008.
609.
PowisG, GasdaskaJR, GasdaskaPY, BerggrenM, KirkpatrickDL, EngmanL, CotgreaveIA, AnguloM, BakerA. Selenium and the thioredoxin redox system: effects on cell growth and death. Oncol Res, 9:303–312. 1997.
610.
PowisG, KirkpatrickDL. Thioredoxin signaling as a target for cancer therapy. Curr Opin Pharmacol, 7:392–397. 2007.
611.
PriggeJR, ErikssonS, IversonSV, MeadeTA, CapecchiMR, ArnérESJ, SchmidtEE. Hepatocyte DNA replication in growing liver requires either glutathione or a single allele of txnrd1. Free Radic Biol Med, 52:803–810. 2012.
612.
ProspériMT, FerbusD, KarczinskiI, GoubinG. A human cDNA corresponding to a gene overexpressed during cell proliferation encodes a product sharing homology with amoebic and bacterial proteins. J Biol Chem, 268:11050–11056. 1993.
613.
QanungoS, StarkeDW, PaiHV, MieyalJJ, NieminenA-L. Glutathione supplementation potentiates hypoxic apoptosis by S-glutathionylation of p65-NFkappaB. J Biol Chem, 282:18427–18436. 2007.
QuD, RashidianJ, MountMP, AleyasinH, ParsanejadM, LiraA, HaqueE, ZhangY, CallaghanS, DaigleM, RousseauxMWC, SlackRS, AlbertPR, VincentI, WoulfeJM, ParkDS. Role of Cdk5-mediated phosphorylation of Prx2 in MPTP toxicity and Parkinson's disease. Neuron, 55:37–52. 2007.
616.
RahlfsS, SchirmerRH, BeckerK. The thioredoxin system of Plasmodium falciparum and other parasites. Cell Mol Life Sci, 59:1024–1041. 2002.
617.
RahmanI, MorrisonD, DonaldsonK, MacNeeW. Systemic oxidative stress in asthma, COPD, and smokers. Am J Respir Crit Care Med, 154:1055–1060. 1996.
618.
RahmanI, Van SchadewijkAA, HiemstraPS, StolkJ, Van KriekenJH, MacNeeW, De BoerWI. Localization of gamma-glutamylcysteine synthetase messenger rna expression in lungs of smokers and patients with chronic obstructive pulmonary disease. Free Radic Biol Med, 28:920–925. 2000.
619.
RajagopalI, AhnBY, MossB, MathewsCK. Roles of vaccinia virus ribonucleotide reductase and glutaredoxin in DNA precursor biosynthesis. J Biol Chem, 270:27415–27418. 1995.
620.
RamalingamM, KimS-J. Reactive oxygen/nitrogen species and their functional correlations in neurodegenerative diseases. J Neural Transm, 119:891–910. 2012.
621.
RaniS, MehtaJP, BarronN, DoolanP, JeppesenPB, ClynesM, O'DriscollL. Decreasing Txnip mRNA and protein levels in pancreatic MIN6 cells reduces reactive oxygen species and restores glucose regulated insulin secretion. Cell Physiol Biochem, 25:667–674. 2010.
622.
RaoRSP, MøllerIM. Pattern of occurrence and occupancy of carbonylation sites in proteins. Proteomics, 11:4166–4173. 2011.
623.
RascheA, Al-HasaniH, HerwigR. Meta-analysis approach identifies candidate genes and associated molecular networks for type-2 diabetes mellitus. BMC Genomics, 9:310. 2008.
624.
RashidianJ, RousseauxMW, VenderovaK, QuD, CallaghanSM, PhillipsM, BlandRJ, DuringMJ, MaoZ, SlackRS, ParkDS. Essential role of cytoplasmic cdk5 and Prx2 in multiple ischemic injury models, in vivo. J Neurosci, 29:12497–12505. 2009.
625.
RattsR, ZengH, BergEA, BlueC, McCombME, CostelloCE, vanderSpekJC, MurphyJR. The cytosolic entry of diphtheria toxin catalytic domain requires a host cell cytosolic translocation factor complex. J Cell Biol, 160:1139–1150. 2003.
626.
RayS, WatkinsDN, MissoNLA, ThompsonPJ. Oxidant stress induces gamma-glutamylcysteine synthetase and glutathione synthesis in human bronchial epithelial NCI-H292 cells. Clin Exp Allergy, 32:571–577. 2002.
627.
RazaH. Dual localization of glutathione S-transferase in the cytosol and mitochondria: implications in oxidative stress, toxicity and disease. FEBS J, 278:4243–4251. 2011.
628.
RebrinI, BayneA-CV, MockettRJ, OrrWC, SohalRS. Free aminothiols, glutathione redox state and protein mixed disulphides in aging Drosophila melanogaster. Biochem J, 382:131–136. 2004.
629.
ReckenfelderbäumerN, Krauth-SiegelRL. Catalytic properties, thiol pK value, and redox potential of Trypanosoma brucei tryparedoxin. J Biol Chem, 277:17548–17555. 2002.
630.
ReddyPG, BhuyanDK, BhuyanKC. Lens-specific regulation of the thioredoxin-1 gene, but not thioredoxin-2, upon in vivo photochemical oxidative stress in the Emory mouse. Biochem Biophys Res Commun, 265:345–349. 1999.
631.
ReichE, TamaryA, SionovRV, MelloulD. Involvement of thioredoxin-interacting protein (TXNIP) in glucocorticoid-mediated beta cell death. Diabetologia, 55:1048–1057. 2012.
ReiserK, FrançoisKO, ScholsD, BergmanT, JörnvallH, BalzariniJ, KarlssonA, LundbergM. Thioredoxin-1 and protein disulfide isomerase catalyze the reduction of similar disulfides in HIV gp120. Int J Biochem Cell Biol, 44:556–562. 2012.
634.
Van RemmenH, IkenoY, HamiltonM, PahlavaniM, WolfN, ThorpeSR, AldersonNL, BaynesJW, EpsteinCJ, HuangT-T, NelsonJ, StrongR, RichardsonA. Life-long reduction in MnSOD activity results in increased DNA damage and higher incidence of cancer but does not accelerate aging. Physiol Genomics, 16:29–37. 2003.
635.
Van RemmenH, RichardsonA. Oxidative damage to mitochondria and aging. Exp Gerontol, 36:957–968. 2001.
636.
ReynaertNL, WoutersEFM, Janssen-HeiningerYMW. Modulation of glutaredoxin-1 expression in a mouse model of allergic airway disease. Am J Respir Cell Mol Biol, 36:147–151. 2007.
637.
De Rey-PailhadeJ. Nouvelle recherches physiologique sur la substance organique hydrogénant le soufre à froid. C R Acad Sci, 107:43–44. 1888.
638.
De Rey-PailhadeJ. Sur un corps d'origine organique hydrogénant le soufre 1 à froid. C R Acad Sci, 106:1683–1684. 1888.
639.
De Rey-PailhadeJ. Sur le role physiologique du soufre. essai 15. 1888. Bull Soc Hist Nat Toulouse.
640.
RheeSG, JeongW, ChangT-S, WooHA. Sulfiredoxin, the cysteine sulfinic acid reductase specific to 2-Cys peroxiredoxin: its discovery, mechanism of action, and biological significance. Kidney Int Suppl, S3–S8. 2007.
641.
RheeSG, KangSW, ChangTS, JeongW, KimK. Peroxiredoxin, a novel family of peroxidases. IUBMB Life, 52:35–41. 2001.
642.
RheeSG, KangSW, NettoLE, SeoMS, StadtmanER. A family of novel peroxidases, peroxiredoxins. Biofactors, 10:207–209. 1999.
643.
RheeSG, WooHA. Multiple functions of peroxiredoxins: peroxidases, sensors and regulators of the intracellular messenger H2O2, and protein chaperones. Antioxid Redox Signal, 15:781–794. 2011.
644.
RietveldA, SijensP, VerkleijAJ, de KruijffB. Interaction of cytochrome c and its precursor apocytochrome c with various phospholipids. EMBO J, 2:907–913. 1983.
645.
RobinsonNC. Functional binding of cardiolipin to cytochrome c oxidase. J Bioenerg Biomembr, 25:153–163. 1993.
646.
RodbellM. Nobel lecture. Signal transduction: evolution of an idea. Biosci Rep, 15:117–133. 1995.
647.
Rodríguez-ManzanequeMT, TamaritJ, BellíG, RosJ, HerreroE. Grx5 is a mitochondrial glutaredoxin required for the activity of iron/sulfur enzymes. Mol Biol Cell, 13:1109–1121. 2002.
648.
RohrbachS, GruenlerS, TeschnerM, HoltzJ. The thioredoxin system in aging muscle: key role of mitochondrial thioredoxin reductase in the protective effects of caloric restriction?Am J Physiol Regul Integr Comp Physiol, 291:R927–R935. 2006.
649.
RollinsMF, Van der HeideDM, WeisendCM, KundertJA, ComstockKM, SuvorovaES, CapecchiMR, MerrillGF, SchmidtEE. Hepatocytes lacking thioredoxin reductase 1 have normal replicative potential during development and regeneration. J Cell Sci, 123:2402–2412. 2010.
650.
RongW, KimuraH, GrundyD. The neurophysiology of hydrogen sulfide. Inflamm Allergy Drug Targets, 10:109–117. 2011.
651.
RothforkJM, TimminsGS, HarrisMN, ChenX, LusisAJ, OttoM, CheungAL, GreshamHD. Inactivation of a bacterial virulence pheromone by phagocyte-derived oxidants: new role for the NADPH oxidase in host defense. Proc Natl Acad Sci U S A, 101:13867–13872. 2004.
652.
RouaultTA. The role of iron regulatory proteins in mammalian iron homeostasis and disease. Nat Chem Biol, 2:406–414. 2006.
653.
RozellB, BárcenaJA, Martínez-GalisteoE, PadillaCA, HolmgrenA. Immunochemical characterization and tissue distribution of glutaredoxin (thioltransferase) from calf. Eur J Cell Biol, 62:314–323. 1993.
654.
RozellB, HanssonHA, LuthmanM, HolmgrenA. Immunohistochemical localization of thioredoxin and thioredoxin reductase in adult rats. Eur J Cell Biol, 38:79–86. 1985.
655.
RubartelliA, BajettoA, AllavenaG, WollmanE, SitiaR. Secretion of thioredoxin by normal and neoplastic cells through a leaderless secretory pathway. J Biol Chem, 267:24161–24164. 1992.
656.
RubartelliA, BonifaciN, SitiaR. High rates of thioredoxin secretion correlate with growth arrest in hepatoma cells. Cancer Res, 55:675–680. 1995.
657.
RundlöfA-K, JanardM, Miranda-VizueteA, ArnérESJ. Evidence for intriguingly complex transcription of human thioredoxin reductase 1. Free Radic Biol Med, 36:641–656. 2004.
658.
RuoppoloM, Lundström-LjungJ, TalamoF, PucciP, MarinoG. Effect of glutaredoxin and protein disulfide isomerase on the glutathione-dependent folding of ribonuclease A. Biochemistry, 36:12259–12267. 1997.
RutledgeBJ, RayburnH, RosenbergR, NorthRJ, GladueRP, CorlessCL, RollinsBJ. High level monocyte chemoattractant protein-1 expression in transgenic mice increases their susceptibility to intracellular pathogens. J Immunol, 155:4838–4843. 1995.
661.
Sabens LiedhegnerEA, GaoX-H, MieyalJJ. Mechanisms of altered redox regulation in neurodegenerative diseases-focus on s-glutathionylation. Antioxid Redox Signal, 16:543–566. 2012.
662.
SackesenC, ErcanH, DizdarE, SoyerO, GumusP, TosunBN, BüyüktuncerZ, KarabulutE, BeslerT, KalayciO. A comprehensive evaluation of the enzymatic and nonenzymatic antioxidant systems in childhood asthma. J Allergy Clin Immunol, 122:78–85. 2008.
663.
SadekCM, DamdimopoulosAE, Pelto-HuikkoM, GustafssonJA, SpyrouG, Miranda-VizueteA. Sptrx-2, a fusion protein composed of one thioredoxin and three tandemly repeated NDP-kinase domains is expressed in human testis germ cells. Genes Cells, 6:1077–1090. 2001.
664.
SadekCM, JiménezA, DamdimopoulosAE, KieselbachT, NordM, GustafssonJ-A, SpyrouG, DavisEC, OkoR, Van der HoornFA, Miranda-VizueteA. Characterization of human thioredoxin-like 2. A novel microtubule-binding thioredoxin expressed predominantly in the cilia of lung airway epithelium and spermatid manchette and axoneme. J Biol Chem, 278:13133–13142. 2003.
665.
SaeedU, RayA, ValliRK, KumarAMR, RavindranathV. DJ-1 loss by glutaredoxin but not glutathione depletion triggers Daxx translocation and cell death. Antioxid Redox Signal, 13:127–144. 2010.
666.
SahafB, RosénA. Secretion of 10-kDa and 12-kDa thioredoxin species from blood monocytes and transformed leukocytes. Antioxid Redox Signal, 2:717–726. 2000.
667.
SahafB, SöderbergA, SpyrouG, BarralAM, PekkariK, HolmgrenA, RosénA. Thioredoxin expression and localization in human cell lines: detection of full-length and truncated species. Exp Cell Res, 236:181–192. 1997.
668.
SahlinL, WangH, StjernholmY, LundbergM, EkmanG, HolmgrenA, ErikssonH. The expression of glutaredoxin is increased in the human cervix in term pregnancy and immediately post-partum, particularly after prostaglandin-induced delivery. Mol Hum Reprod, 6:1147–1153. 2000.
669.
SainiHK, MachackovaJ, DhallaNS. Role of reactive oxygen species in ischemic preconditioning of subcellular organelles in the heart. Antioxid Redox Signal, 6:393–404. 2004.
670.
SaitohM, NishitohH, FujiiM, TakedaK, TobiumeK, SawadaY, KawabataM, MiyazonoK, IchijoH. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J, 17:2596–2606. 1998.
671.
SakaiK, MatsumotoK, NishikawaT, SuefujiM, NakamaruK, HirashimaY, KawashimaJ, ShirotaniT, IchinoseK, BrownleeM, ArakiE. Mitochondrial reactive oxygen species reduce insulin secretion by pancreatic beta-cells. Biochem Biophys Res Commun, 300:216–222. 2003.
672.
SalehD, ErnstP, LimS, BarnesPJ, GiaidA. Increased formation of the potent oxidant peroxynitrite in the airways of asthmatic patients is associated with induction of nitric oxide synthase: effect of inhaled glucocorticoid. FASEB J, 12:929–937. 1998.
673.
SalinasAE, WongMG. Glutathione S-transferases—a review. Curr Med Chem, 6:279–309. 1999.
674.
SamiecPS, Drews-BotschC, FlaggEW, KurtzJC, SternbergPJr., ReedRL, JonesDP. Glutathione in human plasma: decline in association with aging, age-related macular degeneration, and diabetes. Free Radic Biol Med, 24:699–704. 1998.
675.
SamuelSM, ThirunavukkarasuM, PenumathsaSV, KoneruS, ZhanL, MaulikG, SudhakaranPR, MaulikN. Thioredoxin-1 gene therapy enhances angiogenic signaling and reduces ventricular remodeling in infarcted myocardium of diabetic rats. Circulation, 121:1244–1255. 2010.
676.
SandauKB, FandreyJ, BrüneB. Accumulation of HIF-1alpha under the influence of nitric oxide. Blood, 97:1009–1015. 2001.
677.
Sanjuán-PlaA, CerveraAM, ApostolovaN, Garcia-BouR, VíctorVM, MurphyMP, McCreathKJ. A targeted antioxidant reveals the importance of mitochondrial reactive oxygen species in the hypoxic signaling of HIF-1alpha. FEBS Lett, 579:2669–2674. 2005.
678.
SarafianTA, VerityMA, VintersHV, ShihCC, ShiL, JiXD, DongL, ShauH. Differential expression of peroxiredoxin subtypes in human brain cell types. J Neurosci Res, 56:206–212. 1999.
679.
SasagawaI, MatsukiS, SuzukiY, IuchiY, TohyaK, KimuraM, NakadaT, FujiiJ. Possible involvement of the membrane-bound form of peroxiredoxin 4 in acrosome formation during spermiogenesis of rats. Eur J Biochem, 268:3053–3061. 2001.
680.
SastreJ, PallardóFV, ViñaJ. The role of mitochondrial oxidative stress in aging. Free Radic Biol Med, 35:1–8. 2003.
SauriH, ButterfieldL, KimA, ShauH. Antioxidant function of recombinant human natural killer enhancing factor. Biochem Biophys Res Commun, 208:964–969. 1995.
684.
SchapiraAH, JennerP. Etiology and pathogenesis of Parkinson's disease. Mov Disord, 26:1049–1055. 2011.
685.
SchenkH, VogtM, DrögeW, Schulze-OsthoffK. Thioredoxin as a potent costimulus of cytokine expression. J Immunol, 156:765–771. 1996.
686.
SchradersM, LeeK, OostrikJ, HuygenPLM, AliG, HoefslootLH, VeltmanJA, CremersFPM, BasitS, AnsarM, CremersCWRJ, KunstHPM, AhmadW, AdmiraalRJC, LealSM, KremerH. Homozygosity mapping reveals mutations of GRXCR1 as a cause of autosomal-recessive nonsyndromic hearing impairment. Am J Hum Genet, 86:138–147. 2010.
687.
SchreckR, RieberP, BaeuerlePA. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J, 10:2247–2258. 1991.
688.
SchroederBO, WuZ, NudingS, GroscurthS, MarcinowskiM, BeisnerJ, BuchnerJ, SchallerM, StangeEF, WehkampJ. Reduction of disulphide bonds unmasks potent antimicrobial activity of human β-defensin 1. Nature, 469:419–423. 2011.
689.
SchulzePC, De KeulenaerGW, YoshiokaJ, KassikKA, LeeRT. Vitamin D3-upregulated protein-1 (VDUP-1) regulates redox-dependent vascular smooth muscle cell proliferation through interaction with thioredoxin. Circ Res, 91:689–695. 2002.
690.
SchulzePC, YoshiokaJ, TakahashiT, HeZ, KingGL, LeeRT. Hyperglycemia promotes oxidative stress through inhibition of thioredoxin function by thioredoxin-interacting protein. J Biol Chem, 279:30369–30374. 2004.
691.
SeghieriG, Di SimplicioP, De GiorgioLA, AnichiniR, AlbertiL, FranconiF. Relationship between metabolic glycaemic control and platelet content of glutathione and its related enzymes, in insulin-dependent diabetes mellitus. Clin Chim Acta, 299:109–117. 2000.
692.
SekharRV, McKaySV, PatelSG, GuthikondaAP, ReddyVT, BalasubramanyamA, JahoorF. Glutathione synthesis is diminished in patients with uncontrolled diabetes and restored by dietary supplementation with cysteine and glycine. Diabetes Care, 34:162–167. 2011.
693.
SeleniusM, RundlöfA-K, OlmE, FernandesAP, BjörnstedtM. Selenium and the selenoprotein thioredoxin reductase in the prevention, treatment and diagnostics of cancer. Antioxid Redox Signal, 12:867–880. 2010.
SemenzaGL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer, 3:721–732. 2003.
696.
SemenzaGL. Pulmonary vascular responses to chronic hypoxia mediated by hypoxia-inducible factor 1. Proc Am Thorac Soc, 2:68–70. 2005.
697.
SenguptaR, HolmgrenA. The role of thioredoxin in the regulation of cellular processes by S-nitrosylation. Biochim Biophys Acta, 1820:589–700. 2011.
698.
SeoMS, KangSW, KimK, BainesIC, LeeTH, RheeSG. Identification of a new type of mammalian peroxiredoxin that forms an intramolecular disulfide as a reaction intermediate. J Biol Chem, 275:20346–20354. 2000.
699.
SethD, StamlerJS. The SNO-proteome: causation and classifications. Curr Opin Chem Biol, 15:129–136. 2011.
700.
ShakedM, Ketzinel-GiladM, AriavY, CerasiE, KaiserN, LeibowitzG. Insulin counteracts glucotoxic effects by suppressing thioredoxin-interacting protein production in INS-1E beta cells and in Psammomys obesus pancreatic islets. Diabetologia, 52:636–644. 2009.
701.
ShauH, ButterfieldLH, ChiuR, KimA. Cloning and sequence analysis of candidate human natural killer-enhancing factor genes. Immunogenetics, 40:129–134. 1994.
702.
ShauH, MerinoA, ChenL, ShihCC, ColquhounSD. Induction of peroxiredoxins in transplanted livers and demonstration of their in vitro cytoprotection activity. Antioxid Redox Signal, 2:347–354. 2000.
703.
SheltonMD, ChockPB, MieyalJJ. Glutaredoxin: role in Reversible Protein S-Glutathionylation and Regulation of Redox Signal Transduction and Protein Translocation. Antioxid Redox Signal, 7:348–366. 2005.
SheltonMD, KernTS, MieyalJJ. Glutaredoxin regulates nuclear factor kappa-B and intercellular adhesion molecule in Müller cells: model of diabetic retinopathy. J Biol Chem, 282:12467–12474. 2007.
706.
ShibuyaN, TanakaM, YoshidaM, OgasawaraY, TogawaT, IshiiK, KimuraH. 3-Mercaptopyruvate sulfurtransferase produces hydrogen sulfide and bound sulfane sulfur in the brain. Antioxid Redox Signal, 11:703–714. 2009.
707.
ShiojiK, KishimotoC, NakamuraH, MasutaniH, YuanZ, OkaS, YodoiJ. Overexpression of Thioredoxin-1 in Transgenic Mice Attenuates Adriamycin-Induced Cardiotoxicity. Circulation, 106:1403–1409. 2002.
708.
ShiojiK, KishimotoC, NakamuraH, ToyokuniS, NakayamaY, YodoiJ, SasayamaS. Upregulation of thioredoxin (TRX) expression in giant cell myocarditis in rats. FEBS Lett, 472:109–113. 2000.
709.
ShiotaM, YokomizoA, KashiwagiE, TakeuchiA, FujimotoN, UchiumiT, NaitoS. Peroxiredoxin 2 in the nucleus and cytoplasm distinctly regulates androgen receptor activity in prostate cancer cells. Free Radic Biol Med, 51:78–87. 2011.
710.
ShiY, RenY, ZhaoL, DuC, WangY, ZhangY, LiY, ZhaoS, DuanH. Knockdown of thioredoxin interacting protein attenuates high glucose-induced apoptosis and activation of ASK1 in mouse mesangial cells. FEBS Lett, 585:1789–1795. 2011.
711.
ShiZZ, Osei-FrimpongJ, KalaG, KalaSV, BarriosRJ, HabibGM, LukinDJ, DanneyCM, MatzukMM, LiebermanMW. Glutathione synthesis is essential for mouse development but not for cell growth in culture. Proc Natl Acad Sci U S A, 97:5101–5106. 2000.
712.
ShoelsonSE, LeeJ, YuanM. Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity- and diet-induced insulin resistance. Int J Obes Relat Metab Disord, 27,Suppl 3:S49–S52. 2003.
713.
SibbingD, PfeuferA, PerisicT, MannesAM, Fritz-WolfK, UnwinS, SinnerMF, GiegerC, GloecknerCJ, WichmannH-E, KremmerE, SchäferZ, WalchA, HinterseerM, NäbauerM, KääbS, KastratiA, SchömigA, MeitingerT, BornkammGW, ConradM, Von BeckerathN. Mutations in the mitochondrial thioredoxin reductase gene TXNRD2 cause dilated cardiomyopathy. Eur Heart J, 32:1121–1133. 2011.
714.
SiesH. Oxidative stress: from basic research to clinical application. Am J Med, 91:31S–38S. 1991.
715.
SiesH, CadenasE. Oxidative stress: damage to intact cells and organs. Philos Trans R Soc Lond B Biol Sci, 311:617–631. 1985.
716.
SilbersteinDS, AliMH, BakerSL, DavidJR. Human eosinophil cytotoxicity-enhancing factor. Purification, physical characteristics, and partial amino acid sequence of an active polypeptide. J Immunol, 143:979–983. 1989.
717.
SiliprandiR, CanellaR, CarmignotoG, SchiavoN, ZanellatoA, ZanoniR, VantiniG. N-methyl-D-aspartate-induced neurotoxicity in the adult rat retina. Vis Neurosci, 8:567–573. 1992.
718.
SimonetWS, HughesTM, NguyenHQ, TrebaskyLD, DanilenkoDM, MedlockES. Long-term impaired neutrophil migration in mice overexpressing human interleukin-8. J Clin Invest, 94:1310–1319. 1994.
719.
Di SimplicioP, De GiorgioLA, CardaioliE, LecisR, MiceliM, RossiR, AnichiniR, MianM, SeghieriG, FranconiF. Glutathione, glutathione utilizing enzymes and thioltransferase in platelets of insulin-dependent diabetic patients: relation with platelet aggregation and with microangiopatic complications. Eur J Clin Invest, 25:665–669. 1995.
SkellyAH. Type 2 diabetes mellitus. Nurs Clin North Am, 41:531–547. 2006.
722.
SöderbergA, SahafB, RosénA. Thioredoxin reductase, a redox-active selenoprotein, is secreted by normal and neoplastic cells: presence in human plasma. Cancer Res, 60:2281–2289. 2000.
723.
SoderbergBO, HolmgrenA, BrandenCI. Structure of oxidized thioredoxin to 4 with 5 A resolution. J Mol Biol, 90:143–152. 1974.
724.
SoerensenJ, JakupogluC, BeckH, FörsterH, SchmidtJ, SchmahlW, SchweizerU, ConradM, BrielmeierM. The role of thioredoxin reductases in brain development. PLoS One, 3:e1813. 2008.
725.
SogawaK, Numayama-TsurutaK, EmaM, AbeM, AbeH, Fujii-KuriyamaY. Inhibition of hypoxia-inducible factor 1 activity by nitric oxide donors in hypoxia. Proc Natl Acad Sci U S A, 95:7368–7373. 1998.
SohlmanR. The Legacy of Alfred Nobel. London, United Kingdom: The Bodley Head Ltd., 1983.
728.
SoiniY, KallioJP, HirvikoskiP, HelinH, Kellokumpu-LehtinenP, KangSW, TammelaTLJ, PeltoniemiM, MartikainenPM, KinnulaVL. Oxidative/nitrosative stress and peroxiredoxin 2 are associated with grade and prognosis of human renal carcinoma. APMIS, 114:329–337. 2006.
729.
SomaniSM, HusainK. Exercise training alters kinetics of antioxidant enzymes in rat tissues. Biochem Mol Biol Int, 38:587–595. 1996.
730.
SonA, KatoN, HoribeT, MatsuoY, MochizukiM, MitsuiA, KawakamiK, NakamuraH, YodoiJ. Direct association of thioredoxin-1 (TRX) with macrophage migration inhibitory factor (MIF): regulatory role of TRX on MIF internalization and signaling. Antioxid Redox Signal, 11:2595–2605. 2009.
731.
SongJJ, LeeYJ. Differential role of glutaredoxin and thioredoxin in metabolic oxidative stress-induced activation of apoptosis signal-regulating kinase 1. Biochem J, 373:845–853. 2003.
732.
SongJJ, RheeJG, SuntharalingamM, WalshSA, SpitzDR, LeeYJ. Role of glutaredoxin in metabolic oxidative stress. Glutaredoxin as a sensor of oxidative stress mediated by H2O2. J Biol Chem, 277:46566–45675. 2002.
733.
SongJS, ChoHH, LeeB-J, BaeYC, JungJS. Role of thioredoxin 1 and thioredoxin 2 on proliferation of human adipose tissue-derived mesenchymal stem cells. Stem Cells Dev, 20:1529–1537. 2011.
734.
SorokinaEM, FeinsteinSI, MilovanovaTN, FisherAB. Identification of the amino acid sequence that targets peroxiredoxin 6 to lysosome-like structures of lung epithelial cells. Am J Physiol Lung Cell Mol Physiol, 297:L871–L880. 2009.
735.
SorokinaEM, FeinsteinSI, ZhouS, FisherAB. Intracellular targeting of peroxiredoxin 6 to lysosomal organelles requires MAPK activity and binding to 14-3-3ɛAm J Physiol Cell Physiol, 300:C1430–C1441. 2011.
736.
SpyrouG, EnmarkE, Miranda-VizueteA, GustafssonJ. Cloning and expression of a novel mammalian thioredoxin. J Biol Chem, 272:2936–2941. 1997.
737.
StaalFJ, RoedererM, HerzenbergLA, HerzenbergLA. Intracellular thiols regulate activation of nuclear factor kappa B and transcription of human immunodeficiency virus. Proc Natl Acad Sci U S A, 87:9943–9947. 1990.
738.
StadtmanER, LevineRL. Free radical-mediated oxidation of free amino acids and amino acid residues in proteins. Amino Acids, 25:207–218. 2003.
739.
StadtmanER, MoskovitzJ, LevineRL. Oxidation of methionine residues of proteins: biological consequences. Antioxid Redox Signal, 5:577–582. 2003.
740.
StipanukMH, BeckPW. Characterization of the enzymic capacity for cysteine desulphhydration in liver and kidney of the rat. Biochem J, 206:267–277. 1982.
741.
StreyCW, SpellmanD, StieberA, GonatasJO, WangX, LambrisJD, GonatasNK. Dysregulation of stathmin, a microtubule-destabilizing protein, and up-regulation of Hsp25, Hsp27, and the antioxidant peroxiredoxin 6 in a mouse model of familial amyotrophic lateral sclerosis. Am J Pathol, 165:1701–1718. 2004.
742.
StuderL, CseteM, LeeSH, KabbaniN, WalikonisJ, WoldB, McKayR. Enhanced proliferation, survival, and dopaminergic differentiation of CNS precursors in lowered oxygen. J Neurosci, 20:7377–7383. 2000.
743.
SuD, BerndtC, FomenkoDE, HolmgrenA, GladyshevVN. A conserved cis-proline precludes metal binding by the active site thiolates in members of the thioredoxin family of proteins. Biochemistry, 46:6903–6910. 2007.
744.
SuD, NovoselovSV, SunQ-A, MoustafaME, ZhouY, OkoR, HatfieldDL, GladyshevVN. Mammalian selenoprotein thioredoxin-glutathione reductase. Roles in disulfide bond formation and sperm maturation. J Biol Chem, 280:26491–26498. 2005.
745.
SultanaR, Boyd-KimballD, CaiJ, PierceWM, KleinJB, MerchantM, ButterfieldDA. Proteomics analysis of the Alzheimer's disease hippocampal proteome. J Alzheimers Dis, 11:153–164. 2007.
746.
SultanaR, Boyd-KimballD, CaiJ, PierceWM, KleinJB, MerchantM, ButterfieldDA. Proteomics analysis of the Alzheimer's disease hippocampal proteome. J Alzheimers Dis, 11:153–164. 2007.
747.
SutcliffeEL, RaoS. Duplicity of protein kinase C-θ: novel insights into human T-cell biology. Transcription, 2:189–192. 2011.
748.
SvenssonMJ, LarssonJ. Thioredoxin-2 affects lifespan and oxidative stress in Drosophila. Hereditas, 144:25–32. 2007.
749.
SwaroopM, BradleyK, OhuraT, TaharaT, RoperMD, RosenbergLE, KrausJP. Rat cystathionine beta-synthase. Gene organization and alternative splicing. J Biol Chem, 267:11455–11461. 1992.
750.
SylvieJ, EllenC, KrisV. The role of Wnt in cell signaling and cell adhesion during early vertebrate development. Front Biosci, 17:2352–2366. 2012.
751.
TagayaY, MaedaY, MitsuiA, KondoN, MatsuiH, HamuroJ, BrownN, AraiK, YokotaT, WakasugiH. ATL-derived factor (ADF), an IL-2 receptor/Tac inducer homologous to thioredoxin; possible involvement of dithiol-reduction in the IL-2 receptor induction. EMBO J, 8:757–764. 1989.
752.
TakagiY, MitsuiA, NishiyamaA, NozakiK, SonoH, GonY, HashimotoN, YodoiJ. Overexpression of thioredoxin in transgenic mice attenuates focal ischemic brain damage. Proc Natl Acad Sci U S A, 96:4131–4136. 1999.
753.
This reference has been deleted.
754.
TakahashiK-I, ChinK, NakamuraH, MoritaS, SumiK, OgaT, MatsumotoH, NiimiA, FukuharaS, YodoiJ, MishimaM. Plasma thioredoxin, a novel oxidative stress marker, in patients with obstructive sleep apnea before and after nasal continuous positive airway pressure. Antioxid Redox Signal, 10:715–726. 2008.
755.
TakashimaY, HirotaK, NakamuraH, NakamuraT, AkiyamaK, ChengFS, MaedaM, YodoiJ. Differential expression of glutaredoxin and thioredoxin during monocytic differentiation. Immunol Lett, 68:397–401. 1999.
756.
TaketaniY, KinugasaK, FurukawaS, NakamuraH, OtsukiR, YasudaH, FujitaT, KanzakiK, MasutaniH, YodoiJ. Yeast thioredoxin-enriched extracts for mitigating the allergenicity of foods. Biosci Biotechnol Biochem, 75:1872–1879. 2011.
757.
TakeuchiJ, HirotaK, ItohT, ShinkuraR, KitadaK, YodoiJ, NambaT, FukudaK. Thioredoxin inhibits tumor necrosis factor- or interleukin-1-induced NF-kappaB activation at a level upstream of NF-kappaB-inducing kinase. Antioxid Redox Signal, 2:83–92. 2000.
758.
TamakiH, NakamuraH, NishioA, NakaseH, UenoS, UzaN, KidoM, InoueS, MikamiS, AsadaM, KiriyaK, KitamuraH, OhashiS, FukuiT, KawasakiK, MatsuuraM, IshiiY, OkazakiK, YodoiJ, ChibaT. Human thioredoxin-1 ameliorates experimental murine colitis in association with suppressed macrophage inhibitory factor production. Gastroenterology, 131:1110–1121. 2006.
TangK, LiX, ZhengM-Q, RozanskiGJ. Role of apoptosis signal-regulating kinase-1-c-Jun NH2-terminal kinase-p38 signaling in voltage-gated K+ channel remodeling of the failing heart: regulation by thioredoxin. Antioxid Redox Signal, 14:25–35. 2011.
761.
TaniguchiY, Taniguchi-UedaY, MoriK, YodoiJ. A novel promoter sequence is involved in the oxidative stress-induced expression of the adult T-cell leukemia-derived factor (ADF)/human thioredoxin (Trx) gene. Nucleic Acids Res, 24:2746–2752. 1996.
762.
TanitoM, AgbagaM-P, AndersonRE. Upregulation of thioredoxin system via Nrf2-antioxidant responsive element pathway in adaptive-retinal neuroprotection in vivo and in vitro. Free Radic Biol Med, 42:1838–1850. 2007.
763.
TanitoM, MasutaniH, NakamuraH, OhiraA, YodoiJ. Cytoprotective effect of thioredoxin against retinal photic injury in mice. Invest Ophthalmol Vis Sci, 43:1162–1167. 2002.
764.
TanitoM, NishiyamaA, TanakaT, MasutaniH, NakamuraH, YodoiJ, OhiraA. Change of redox status and modulation by thiol replenishment in retinal photooxidative damage. Invest Ophthalmol Vis Sci, 43:2392–2400. 2002.
765.
TannenbaumSR, WhiteFM. Regulation and specificity of S-nitrosylation and denitrosylation. ACS Chem Biol, 1:615–618. 2006.
766.
TanSM, ZhangY, CoxAJ, KellyDJ, QiW. Tranilast attenuates the up-regulation of thioredoxin-interacting protein and oxidative stress in an experimental model of diabetic nephropathy. Nephrol Dial Transplant, 26:100–110. 2011.
767.
TaoL, GaoE, BryanNS, QuY, LiuH-R, HuA, ChristopherTA, LopezBL, YodoiJ, KochWJ, FeelischM, MaXL. Cardioprotective effects of thioredoxin in myocardial ischemia and reperfusion: role of S-nitrosation [corrected]Proc Natl Acad Sci U S A, 101:11471–11476. 2004.
TaoL, JiaoX, GaoE, LauWB, YuanY, LopezB, ChristopherT, RamachandraRaoSP, WilliamsW, SouthanG, SharmaK, KochW, MaXL. Nitrative inactivation of thioredoxin-1 and its role in postischemic myocardial apoptosis. Circulation, 114:1395–1402. 2006.
770.
TaubJ, LauJF, MaC, HahnJH, HoqueR, RothblattJ, ChalfieM. A cytosolic catalase is needed to extend adult lifespan in C. elegans daf-C and clk-1 mutants. Nature, 399:162–166. 1999.
771.
TezelG. The immune response in glaucoma: a perspective on the roles of oxidative stress. Exp Eye Res, 93:178–186. 2011.
772.
ThénardLJ. Observations sur des nouvelles combinaisons entre l'oxigène et divers acides. Ann Chim Phys, 8:306–312. 1818.
773.
ThielUJE, FeltensR, AdryanB, GieringerR, BrochhausenC, SchuonR, FilliesT, GrusF, MannWJ, BriegerJ. Analysis of differentially expressed proteins in oral squamous cell carcinoma by MALDI-TOF MS. J Oral Pathol Med, 40:369–379. 2011.
774.
TiittoL, Kaarteenaho-WiikR, SormunenR, HolmgrenA, PääkköP, SoiniY, KinnulaVL. Expression of the thioredoxin system in interstitial lung disease. J Pathol, 201:363–370. 2003.
775.
TimmermannB, JarolimS, RussmayerH, KerickM, MichelS, KrügerA, BluemleinK, LaunP, GrillariJ, LehrachH, BreitenbachM, RalserM. A new dominant peroxiredoxin allele identified by whole-genome re-sequencing of random mutagenized yeast causes oxidant-resistance and premature aging. Aging (Albany NY), 2:475–486. 2010.
776.
TodorokiY, TsukaharaH, OhshimaY, ShukunamiK-I, NishijimaK, KotsujiF, HataA, KasugaK, SekineK, NakamuraH, YodoiJ, MayumiM. Concentrations of thioredoxin, a redox-regulating protein, in umbilical cord blood and breast milk. Free Radic Res, 39:291–297. 2005.
777.
TonissenKF, Di TrapaniG. Thioredoxin system inhibitors as mediators of apoptosis for cancer therapy. Mol Nutr Food Res, 53:87–103. 2009.
778.
ToppoS, FlohéL, UrsiniF, VaninS, MaiorinoM. Catalytic mechanisms and specificities of glutathione peroxidases: variations of a basic scheme. Biochim Biophys Acta, 1790:1486–1500. 2009.
TownsendDM, TewKD, TapieroH. The importance of glutathione in human disease. Biomed Pharmacother, 57:145–155. 2003.
781.
TrifunovicA, HanssonA, WredenbergA, RovioAT, DufourE, KhvorostovI, SpelbrinkJN, WibomR, JacobsHT, LarssonN-G. Somatic mtDNA mutations cause aging phenotypes without affecting reactive oxygen species production. Proc Natl Acad Sci U S A, 102:17993–17998. 2005.
782.
TruscottRJW. Age-related nuclear cataract-oxidation is the key. Exp Eye Res, 80:709–725. 2005.
783.
TseHM, MiltonMJ, SchreinerS, ProfozichJL, TruccoM, PiganelliJD. Disruption of innate-mediated proinflammatory cytokine and reactive oxygen species third signal leads to antigen-specific hyporesponsiveness. J Immunol, 178:908–917. 2007.
TuranovAA, SuD, GladyshevVN. Characterization of alternative cytosolic forms and cellular targets of mouse mitochondrial thioredoxin reductase. J Biol Chem, 281:22953–22963. 2006.
786.
TurocziT, ChangVW-H, EngelmanRM, MaulikN, HoYS, DasDK. Thioredoxin redox signaling in the ischemic heart: an insight with transgenic mice overexpressing Trx1. J Mol Cell Cardiol, 35:695–704. 2003.
787.
TurunenN, KarihtalaP, MantyniemiA, SormunenR, HolmgrenA, KinnulaVL, SoiniY. Thioredoxin is associated with proliferation, p53 expression and negative estrogen and progesterone receptor status in breast carcinoma. APMIS, 112:123–132. 2004.
788.
TytherR, AhmedaA, JohnsE, SheehanD. Proteomic identification of tyrosine nitration targets in kidney of spontaneously hypertensive rats. Proteomics, 7:4555–4564. 2007.
UgarteN, PetropoulosI, FriguetB. Oxidized mitochondrial protein degradation and repair in aging and oxidative stress. Antioxid Redox Signal, 13:539–549. 2010.
791.
UllrichV, KissnerR. Redox signaling: bioinorganic chemistry at its best. J Inorg Biochem, 100:2079–2086. 2006.
792.
UmarS, Van der LaarseA. Nitric oxide and nitric oxide synthase isoforms in the normal, hypertrophic, and failing heart. Mol Cell Biochem, 333:191–201. 2010.
793.
UrigS, BeckerK. On the potential of thioredoxin reductase inhibitors for cancer therapy. Semin Cancer Biol, 16:452–465. 2006.
794.
UrsiniF, HeimS, KiessM, MaiorinoM, RoveriA, WissingJ, FlohéL. Dual function of the selenoprotein PHGPx during sperm maturation. Science, 285:1393–1396. 1999.
795.
ValdmanA, HäggarthL, ChengL, Lopez-BeltranA, MontironiR, EkmanP, EgevadL. Expression of redox pathway enzymes in human prostatic tissue. Anal Quant Cytol Histol, 31:367–374. 2009.
796.
Del ValG, YeeBC, LozanoRM, BuchananBB, ErmelRW, LeeYM, FrickOL. Thioredoxin treatment increases digestibility and lowers allergenicity of milk. J Allergy Clin Immunol, 103:690–697. 1999.
797.
Vinten-JohansenJ, ZhaoZ-Q, JiangR, ZattaAJ, DobsonGP. Preconditioning and postconditioning: innate cardioprotection from ischemia-reperfusion injury. J Appl Physiol, 103:1441–1448. 2007.
798.
WakasugiN, TagayaY, WakasugiH, MitsuiA, MaedaM, YodoiJ, TurszT. Adult T-cell leukemia-derived factor/thioredoxin, produced by both human T-lymphotropic virus type I- and Epstein-Barr virus-transformed lymphocytes, acts as an autocrine growth factor and synergizes with interleukin 1 and interleukin 2. Proc Natl Acad Sci U S A, 87:8282–8286. 1990.
799.
WangJ, SilvaJP, GustafssonCM, RustinP, LarssonNG. Increased in vivo apoptosis in cells lacking mitochondrial DNA gene expression. Proc Natl Acad Sci U S A, 98:4038–4043. 2001.
800.
WangMX, WeiA, YuanJ, TrickettA, KnoopsB, MurrellGAC. Expression and regulation of peroxiredoxin 5 in human osteoarthritis. FEBS Lett, 531:359–362. 2002.
801.
WangR. Signaling pathways for the vascular effects of hydrogen sulfide. Curr Opin Nephrol Hypertens, 20:107–112. 2011.
802.
WangX, PhelanSA, Forsman-SembK, TaylorEF, PetrosC, BrownA, LernerCP, PaigenB. Mice with targeted mutation of peroxiredoxin 6 develop normally but are susceptible to oxidative stress. J Biol Chem, 278:25179–25190. 2003.
803.
WangX, PhelanSA, PetrosC, TaylorEF, LedinskiG, JürgensG, Forsman-SembK, PaigenB. Peroxiredoxin 6 deficiency and atherosclerosis susceptibility in mice: significance of genetic background for assessing atherosclerosis. Atherosclerosis, 177:61–70. 2004.
804.
WangY, PhelanSA, ManevichY, FeinsteinSI, FisherAB. Transgenic mice overexpressing peroxiredoxin 6 show increased resistance to lung injury in hyperoxia. Am J Respir Cell Mol Biol, 34:481–486. 2006.
805.
WatabeS, HiroiT, YamamotoY, FujiokaY, HasegawaH, YagoN, TakahashiSY. SP-22 is a thioredoxin-dependent peroxide reductase in mitochondria. Eur J Biochem, 249:52–60. 1997.
806.
WebsterCM, KellyS, KoikeMA, ChockVY, GiffardRG, YenariMA. Inflammation and NFkappaB activation is decreased by hypothermia following global cerebral ischemia. Neurobiol Dis, 33:301–312. 2009.
807.
WeiQ, JiangH, XiaoZ, BakerA, YoungMR, VeenstraTD, ColburnNH. Sulfiredoxin-Peroxiredoxin IV axis promotes human lung cancer progression through modulation of specific phosphokinase signaling. Proc Natl Acad Sci U S A, 108:7004–7009. 2011.
808.
WeissG, GoossenB, DopplerW, FuchsD, PantopoulosK, Werner-FelmayerG, WachterH, HentzeMW. Translational regulation via iron-responsive elements by the nitric oxide/NO-synthase pathway. EMBO J, 12:3651–3657. 1993.
WenST, Van EttenRA. The PAG gene product, a stress-induced protein with antioxidant properties, is an Abl SH3-binding protein and a physiological inhibitor of c-Abl tyrosine kinase activity. Genes Dev, 11:2456–2467. 1997.
811.
WhiteCL, SenkevichTG, MossB. Vaccinia virus G4L glutaredoxin is an essential intermediate of a cytoplasmic disulfide bond pathway required for virion assembly. J Virol, 76:467–472. 2002.
812.
WhiteCL, WeisbergAS, MossB. A glutaredoxin, encoded by the G4L gene of vaccinia virus, is essential for virion morphogenesis. J Virol, 74:9175–9183. 2000.
813.
WhitemanM, MoorePK. Hydrogen sulfide and the vasculature: a novel vasculoprotective entity and regulator of nitric oxide bioavailability?J Cell Mol Med, 13:488–507. 2009.
814.
WidderJD, FraccarolloD, GaluppoP, HansenJM, JonesDP, ErtlG, BauersachsJ. Attenuation of angiotensin II-induced vascular dysfunction and hypertension by overexpression of Thioredoxin 2. Hypertension, 54:338–344. 2009.
815.
WiekowskiMT, ChenSC, ZalameaP, WilburnBP, KinsleyDJ, SharifWW, JensenKK, HedrickJA, ManfraD, LiraSA. Disruption of neutrophil migration in a conditional transgenic model: evidence for CXCR2 desensitization in vivo. J Immunol, 167:7102–7110. 2001.
816.
WilsonRB. Iron dysregulation in Friedreich ataxia. Semin Pediatr Neurol, 13:166–175. 2006.
WinklerA, NjålssonR, CarlssonK, ElgadiA, RozellB, AbrahamL, ErcalN, ShiZ-Z, LiebermanMW, LarssonA, NorgrenS. Glutathione is essential for early embryogenesis—analysis of a glutathione synthetase knockout mouse. Biochem Biophys Res Commun, 412:121–126. 2011.
819.
WitteS, VillalbaM, BiK, LiuY, IsakovN, AltmanA. Inhibition of the c-Jun N-terminal kinase/AP-1 and NF-kappaB pathways by PICOT, a novel protein kinase C-interacting protein with a thioredoxin homology domain. J Biol Chem, 275:1902–1909. 2000.
WolinMS, AhmadM, GupteSA. The sources of oxidative stress in the vessel wall. Kidney Int, 67:1659–1661. 2005.
822.
WoodZA, SchröderE, Robin HarrisJ, PooleLB. Structure, mechanism and regulation of peroxiredoxins. Trends Biochem Sci, 28:32–40. 2003.
823.
WooH-J, BaeCH, SongS-Y, KimY-W, LeeH-M, KimY-D. Expression of glutaredoxin-1 in nasal polyps and airway epithelial cells. Am J Rhinol Allergy, 23:288–293. 2009.
824.
WoolstonCM, DeenS, Al-AttarA, ShehataM, ChanSY, MartinSG. Redox protein expression predicts progression-free and overall survival in ovarian cancer patients treated with platinum-based chemotherapy. Free Radic Biol Med, 49:1263–1272. 2010.
825.
WoolstonCM, StorrSJ, EllisIO, MorganDAL, MartinSG. Expression of thioredoxin system and related peroxiredoxin proteins is associated with clinical outcome in radiotherapy treated early stage breast cancer. Radiother Oncol, 100:308–313. 2011.
WuH, XingK, LouMF. Glutaredoxin 2 prevents H(2)O(2)-induced cell apoptosis by protecting complex I activity in the mitochondria. Biochim Biophys Acta, 1797:1705–1715. 2010.
828.
WuJ, TangQ, ShenJ, YaoA, WangF, PuL, YuY, LiX, LiG, ZhangF, SunB, KongL, LiD, ZhangY, GuoX, WangX. Comparative proteome profile during the early period of small-for-size liver transplantation in rats revealed the protective role of Prdx5. J Hepatol, 53:73–83. 2010.
829.
WuX, TengZ, JiangL, FanY, ZhangY, LiX, ZhangY. Human thioredoxin exerts cardioprotective effect and attenuates reperfusion injury in rats partially via inhibiting apoptosis. Chin Med J, 121:819–826. 2008.
XiaTH, BushwellerJH, SodanoP, BilleterM, BjörnbergO, HolmgrenA, WüthrichK. NMR structure of oxidized Escherichia coli glutaredoxin: comparison with reduced E. coli glutaredoxin and functionally related proteins. Protein Sci, 1:310–321. 1992.
832.
XingK-Y, LouMF. Effect of age on the thioltransferase (glutaredoxin) and thioredoxin systems in the human lens. Invest Ophthalmol Vis Sci, 51:6598–6604. 2010.
833.
XiongY, UysJD, TewKD, TownsendDM. S-glutathionylation: from molecular mechanisms to health outcomes. Antioxid Redox Signal, 15:233–270. 2011.
834.
YakesFM, Van HoutenB. Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc Natl Acad Sci U S A, 94:514–519. 1997.
835.
YamadaY, NakamuraH, AdachiT, SannoheS, OyamadaH, KayabaH, YodoiJ, ChiharaJ. Elevated serum levels of thioredoxin in patients with acute exacerbation of asthma. Immunol Lett, 86:199–205. 2003.
836.
YamaguchiT, SanoK, TakakuraK, SaitoI, ShinoharaY, AsanoT, YasuharaH. Ebselen in acute ischemic stroke: a placebo-controlled, double-blind clinical trial. Ebselen Study Group. Stroke, 29:12–17. 1998.
837.
YamamotoM, YamatoE, ToyodaS-I, TashiroF, IkegamiH, YodoiJ, MiyazakiJ-I. Transgenic expression of antioxidant protein thioredoxin in pancreatic beta cells prevents progression of type 2 diabetes mellitus. Antioxid Redox Signal, 10:43–49. 2008.
838.
YamamotoM, YangG, HongC, LiuJ, HolleE, YuX, WagnerT, VatnerSF, SadoshimaJ. Inhibition of endogenous thioredoxin in the heart increases oxidative stress and cardiac hypertrophy. J Clin Invest, 112:1395–1406. 2003.
839.
YamanakaH, MaehiraF, OshiroM, AsatoT, YanagawaY, TakeiH, NakashimaY. A possible interaction of thioredoxin with VDUP1 in HeLa cells detected in a yeast two-hybrid system. Biochem Biophys Res Commun, 271:796–800. 2000.
840.
YanagawaT, IshikawaT, IshiiT, TabuchiK, IwasaS, BannaiS, OmuraK, SuzukiH, YoshidaH. Peroxiredoxin I expression in human thyroid tumors. Cancer Lett, 145:127–132. 1999.
841.
YanagawaT, IwasaS, IshiiT, TabuchiK, YusaH, OnizawaK, OmuraK, HaradaH, SuzukiH, YoshidaH. Peroxiredoxin I expression in oral cancer: a potential new tumor marker. Cancer Lett, 156:27–35. 2000.
842.
YanagawaT, OmuraK, HaradaH, IshiiT, UwayamaJ, NakasoK, IwasaS, KoyamaY, OnizawaK, YusaH, YoshidaH. Peroxiredoxin I expression in tongue squamous cell carcinomas as involved in tumor recurrence. Int J Oral Maxillofac Surg, 34:915–920. 2005.
843.
YangH-Y, KwonJ, ChoE-J, ChoiH-I, ParkC, ParkH-R, ParkS-H, ChungK-J, RyooZY, ChoK-O, LeeT-H. Proteomic analysis of protein expression affected by peroxiredoxin V knock-down in hypoxic kidney. J Proteome Res, 9:4003–4015. 2010.
844.
YangS, LuoA, HaoX, LaiZ, DingT, MaX, MayinuerM, ShenW, WangX, LuY, MaD, WangS. Peroxiredoxin 2 inhibits granulosa cell apoptosis during follicle atresia through the NFKB pathway in mice. Biol Reprod, 84:1182–1189. 2011.
YanY, SabharwalP, RaoM, SockanathanS. The antioxidant enzyme Prdx1 controls neuronal differentiation by thiol-redox-dependent activation of GDE2. Cell, 138:1209–1221. 2009.
847.
YaoJ, TaylorM, DaveyF, RenY, AitonJ, CooteP, FangF, ChenJX, YanSD, Gunn-MooreFJ. Interaction of amyloid binding alcohol dehydrogenase/Abeta mediates up-regulation of peroxiredoxin II in the brains of Alzheimer's disease patients and a transgenic Alzheimer's disease mouse model. Mol Cell Neurosci, 35:377–382. 2007.
848.
YegorovaS, YegorovO, LouMF. Thioredoxin induced antioxidant gene expressions in human lens epithelial cells. Exp Eye Res, 83:783–792. 2006.
849.
YinT, HouR, LiuS, LauWB, WangH, TaoL. Nitrative inactivation of thioredoxin-1 increases vulnerability of diabetic hearts to ischemia/reperfusion injury. J Mol Cell Cardiol, 49:354–361. 2010.
YoshidaT, OkaS, MasutaniH, NakamuraH, YodoiJ. The role of thioredoxin in the aging process: involvement of oxidative stress. Antioxid Redox Signal, 5:563–570. 2003.
853.
YoshidaY, YoshikawaA, KinumiT, OgawaY, SaitoY, OharaK, YamamotoH, ImaiY, NikiE. Hydroxyoctadecadienoic acid and oxidatively modified peroxiredoxins in the blood of Alzheimer's disease patients and their potential as biomarkers. Neurobiol Aging, 30:174–185. 2009.
854.
YoshiharaE, FujimotoS, InagakiN, OkawaK, MasakiS, YodoiJ, MasutaniH. Disruption of TBP-2 ameliorates insulin sensitivity and secretion without affecting obesity. Nat Commun, 1:127. 2010.
855.
YoshiokaJ, ChutkowWA, LeeS, KimJB, YanJ, TianR, LindseyML, FeenerEP, SeidmanCE, SeidmanJG, LeeRT. Deletion of thioredoxin-interacting protein in mice impairs mitochondrial function but protects the myocardium from ischemia-reperfusion injury. J Clin Invest, 122:267–279. 2012.
856.
YoshiokaJ, ImahashiK, GabelSA, ChutkowWA, BurdsAA, GannonJ, SchulzePC, MacGillivrayC, LondonRE, MurphyE, LeeRT. Targeted deletion of thioredoxin-interacting protein regulates cardiac dysfunction in response to pressure overload. Circ Res, 101:1328–1338. 2007.
857.
YoshiokaJ, SchulzePC, CupesiM, SylvanJD, MacGillivrayC, GannonJ, HuangH, LeeRT. Thioredoxin-interacting protein controls cardiac hypertrophy through regulation of thioredoxin activity. Circulation, 109:2581–2586. 2004.
ZelkoIN, MarianiTJ, FolzRJ. Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Radic Biol Med, 33:337–349. 2002.
860.
ZellerT, KlugG. Thioredoxins in bacteria: functions in oxidative stress response and regulation of thioredoxin genes. Naturwissenschaften, 93:259–266. 2006.
861.
Von ZglinickiT, SaretzkiG, DöckeW, LotzeC. Mild hyperoxia shortens telomeres and inhibits proliferation of fibroblasts: a model for senescence?Exp Cell Res, 220:186–193. 1995.
862.
ZhangB, WangY, SuY. Peroxiredoxins, a novel target in cancer radiotherapy. Cancer Lett, 286:154–160. 2009.
863.
ZhangH, LuoY, ZhangW, HeY, DaiS, ZhangR, HuangY, BernatchezP, GiordanoFJ, ShadelG, SessaWC, MinW. Endothelial-specific expression of mitochondrial thioredoxin improves endothelial cell function and reduces atherosclerotic lesions. Am J Pathol, 170:1108–1120. 2007.
864.
ZhangH, TaoL, JiaoX, GaoE, LopezBL, ChristopherTA, KochW, MaXL. Nitrative thioredoxin inactivation as a cause of enhanced myocardial ischemia/reperfusion injury in the aging heart. Free Radic Biol Med, 43:39–47. 2007.
865.
ZhangSX, Garcia-GrasE, WycuffDR, MarriotSJ, KadeerN, YuW, OlsonEN, GarryDJ, ParmacekMS, SchwartzRJ. Identification of direct serum-response factor gene targets during Me2SO-induced P19 cardiac cell differentiation. J Biol Chem, 280:19115–19126. 2005.
866.
ZhangY, IkenoY, QiW, ChaudhuriA, LiY, BokovA, ThorpeSR, BaynesJW, EpsteinC, RichardsonA, Van RemmenH. Mice deficient in both Mn superoxide dismutase and glutathione peroxidase-1 have increased oxidative damage and a greater incidence of pathology but no reduction in longevity. J Gerontol A Biol Sci Med Sci, 64:1212–1220. 2009.
867.
ZhaoR, HolmgrenA. A novel antioxidant mechanism of ebselen involving ebselen diselenide, a substrate of mammalian thioredoxin and thioredoxin reductase. J Biol Chem, 277:39456–39462. 2002.
868.
ZhouF, GomiM, FujimotoM, HayaseM, MarumoT, MasutaniH, YodoiJ, HashimotoN, NozakiK, TakagiY. Attenuation of neuronal degeneration in thioredoxin-1 overexpressing mice after mild focal ischemia. Brain Res, 1272:62–70. 2009.
869.
ZhouJ, DamdimopoulosAE, SpyrouG, BrüneB. Thioredoxin 1 and thioredoxin 2 have opposed regulatory functions on hypoxia-inducible factor-1alpha. J Biol Chem, 282:7482–7490. 2007.
870.
ZhouY, KokKH, ChunAC, WongCM, WuHW, LinMC, FungPC, KungH, JinDY. Mouse peroxiredoxin V is a thioredoxin peroxidase that inhibits p53-induced apoptosis. Biochem Biophys Res Commun, 268:921–927. 2000.
871.
ZhuX, HuangC, PengB. Overexpression of thioredoxin system proteins predicts poor prognosis in patients with squamous cell carcinoma of the tongue. Oral Oncol, 47:609–614. 2011.
